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Zusammenfassung
Biofilme sind Aggregate von Bakterien, welche in einer selbst produzierten Matrix einge-
bettet sind. In der Natur existieren die meisten Bakterien in Form von Biofilmen. Diese
sind außergewöhnlich resistent gegen Umweltstress. Sie können raue Umweltbedingungen
wie Hunger und Austrocknung überleben und herkömmlichen antimikrobiellen Substanzen
widerstehen. Bakterien in Form von Biofilmen verursachen eine Reihe von Krankheiten
in Menschen, Tieren und Pflanzen. Die Bildung von Biofilmen führt zu Korrosion von
Rohrleitungen und verursacht immense Verluste in der Industrie. Der Hauptfokus der
mikrobiologischen Forschung verlagert sich zunehmend in Richtung der Biofilme, wobei
Forscher Strategien zur Bekämpfung von Biofilmen untersuchen.
Unter den verschiedenen Strategien zur Bekämpfung von Biofilmen besitzen biologische
Methoden einige Vorteile gegenber anderen Methoden. Biologische Methoden nutzen
bereits existierende Signalwege in Bakterien aus und bewirken eine effiziente Zersetzung
des Zielbiofilms ohne die Verwendung von künstlich synthetisierten Substanzen. Solche
Methoden sind insbesondere attraktiv für die Behandlung von Biofilmen, die Krankheiten
verursachen. In diesem Projekt habe ich drei verschiedene Strategien ergründet, um Es-
cherichia coli für die Zersetzung von E. coli - und Staphylococcus-Biofilmen zu konstru-
ieren. Das in allen drei Strategien verwendete Anti-Biofilm-Agens ist Dispersin B. Dieses
Enzym hydrolysiert Poly-N-Acetyl-Glucosamin, welches ein Bestandteil der Matrix der Ziel-
biofilme ist. Die Hydrolyse dieses Polymers führt zur Zersetzung des Biofilms.
In der ersten Strategie wird die N-Acetylglucosamin Signaltransduktion, sowie die chemo-
taktische Antwort in E. coli zu Hilfe genommen um den Zielbiofilm zu detektieren und Dis-
persin B zu synthetisieren. N-Acetylglucosamin induziert und erhöht hierbei die Synthese
von Dispersin B. In der zweiten Strategie wird das Biofilm-spezifische Muster der Genex-
pression in E. coli ausgenutzt. Das gentechnisch veränderte Bakterium produziert Dis-
persin B durch die Aktivierung eines Promoters, der unter Biofilm Bedingungen mehrfach
hochreguliert wird. Dabei wird dasBakterium selbst Teil Biofilms und zerstört diesen durch
die Wirkung von Dispersin B. Die dritte Strategie zielt spezifisch auf dei Zerstörung des
s. Epidermis Biofilms. Hierbei wird „Quorum Sensing“ in S. epidermidis ausgenutzt um
den Zielbiofilm zu detektieren und um Dispersin B zu synthetisieren.
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Die in dieser Arbeit vorgeschlagenen Strategien waren partiell erfolgreich. E. coli konnte
gentechnisch verändert werden um Dispersion B zu exprimieren und zu sekretieren und
um somit den Zielbiofilm effizient zu zerstören. Die vorgeschlagenen Strategien sind viel-
seitig anwendbar und können genetisch modifiziert werden um in ähnlichen biologischen
Systemen gegen Biofilime andererSpezien wirksam zu werden. Im Rahmen dieser Arbeit
habe ich unerwartete aspekte des N-Acetylglucosamin Signalweges in E. coli untersucht.
Die Transkriptomanalyse von E. coli Biofilmen hat eine Hochregulierung von Redox-Stress
assoziierten Genen in angehefteten Zellen ergeben. Dieser interessante Aspekt sollte weit-
erhin hinsichtlich der bakteriellen Signaltransduktion und der Biofilmbildung untersucht
werden.
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Abstract
Biofilms are aggregates of bacteria embedded in a self-produced matrix. In nature most
bacteria exist in the form of biofilms. They are exceptionally resistant to environmen-
tal stress. They can survive harsh conditions such as starvation and desiccation, and
can withstand conventional antimicrobial agents. Bacteria in the form of biofilms cause
many diseases in humans, animals and plants. Formation of biofilms leads to corrosion of
pipelines incurring huge losses in industries. The major focus of the research in microbi-
ology is now shifting to biofilms. Researchers are exploring various strategies to combat
biofilms.
Among different methods of combating biofilms, biological methods offer some advantages
over other methods. The biological methods make use of the existing signaling pathways
in bacteria and bring about efficient disruption of the target biofilm without having to
add any artificially synthesized compound. These methods are particularly attractive in
treating biofilm-induced diseases. In this project I have proposed three different strategies
of engineering Escherichia coli to disrupt the biofilms of E. coli and Staphylococcus epi-
dermidis. The anti-biofilm agent used in all the strategies is Dispersin B, an enzyme that
hydrolyzes poly-N-acetyl glucosamine found in the matrix of the target biofilms. Hydrolysis
of this polymer leads to disruption of the biofilm.
The first strategy makes use of the N-acetyl glucosamine signaling and chemotaxis pathway
of E. coli to detect the target biofilm and to synthesize Dispersin B. The product of the
action of Dispersin B is N-acetyl glucosamine, which acts as an inducer to elevate the
synthesis of Dispersin B. The second strategy exploits the biofilm-specific pattern of gene
expression in E. coli biofilms. The engineered bacterium expresses Dispersin B from the
promoter of a gene that is multi-fold activated when the bacterium acquires the biofilm-
lifestyle. It incorporates itself in the target biofilm and disrupts the biofilm through the
action of Dispersin B. The third strategy is specifically aimed at disrupting S. epidermidis
biofilms. It uses the agr quorum-sensing system of S. epidermidis to detect the target
biofilm and to synthesize Dispersin B.
v
The strategies proposed in this project have been partially successful. I have demonstrated
that E. coli can be engineered to express and secrete Dispersin B, which can disrupt the
target biofilm efficiently. The strategies proposed in this project are versatile in application.
They can be modified to engineer similar biological systems against biofilms of other species
of bacteria. In the course of accomplishing the objective of this project I have explored
some unknown aspects of the N-acetyl glucosamine signaling in E. coli. The analysis of the
transcriptome of E. coli biofilms has revealed the up regulation of redox stress-associated
genes in the attached cells of E. coli biofilms. These interesting findings can lead us to
explore further into bacterial signaling and biofilm formation.
vi
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Part I.
Introduction
1
1. Biofilms – what we know so far
In the late 17th century Antonie van Leeuwenhoek having viewed human dental plaque
under a self-made microscope, recorded observations that would be regarded as a pio-
neering for modern Microbiology. In one of his letters to the Royal Society of London he
mentioned “the number of these animalcules in a scurf of man’s teeth are so many that
I believe they exceed the number of men in a kingdom”. Since then microbiology has
grown vast. However, the field focused for the majority of its history on pure cultures of
bacteria suspended in shaken liquid. In the mid 20th century, some researchers realized
that most bacteria in nature survive in the form of slime or as films attached to surfaces
(Heukelekian & Heller, 1940). Such aggregates of bacteria attached to a surface were
later defined as biofilms. What Leeuwenhoek had seen in a dental plaque was actually
the very first microscopic observation of a biofilm. By the late 20th century, scientists
had developed tools and techniques to study these bacterial aggregates, and the study of
biofilms has since evolved into a central focus of microbiology.
Biofilms are aggregates of microbial cells embedded in a self-produced matrix. They grow
on a wide variety of biotic and abiotic surfaces such as living tissues, indwelling medical
devices, inner surfaces of pipes, surfaces of submerged rocks. They are exceptionally
tolerant to environmental stresses including desiccation, lack of nutrients, shear-forces and
attack by hosts’ immune system. With the advent of Confocal Laser Scanning Microscopy
(CLSM) it has been possible to study the structure of biofilms in detail. Biofilms are
now known to possess complex three-dimensional structures that are critical to many of
their collective properties. Figure 1.1 provides a brief summary of a typical biofilm life
cycle (Stoodley et al. , 2002). Planktonic cells attach to a surface irreversibly, begin
secreting extracellular matrix and grow to produce a micro-colony. These micro-colonies
grow further and form a complex three-dimensional structure. Within a mature biofilm,
cells differentiate to perform different functions. Spontaneously or in response to stresses
such as starvation, some cells detach from biofilms back into the planktonic phase, allowing
them to disperse and form a biofilm somewhere else. A great deal of information is now
known regarding molecular mechanisms of biofilm formation and maturation (López et al.
, 2010; Karatan & Watnick, 2009).
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Figure 1.1. – Schematic of biofilm formation (The Image library of Center for Biofilm Engineering,
Montana State University)
1.1. Why do bacteria form biofilms?
The growth rate of bacteria that are embedded in a matrix is certainly lower than that of
planktonic cells. However, in nature most bacteria are seen to exist in a biofilm lifestyle.
The biofilm lifestyle offers several other advantages to bacteria that counter-balance the
disadvantage of slowed growth. Attachment to a surface makes bacteria stay in their
preferred niche. For example, oral Streptococci usually tend to bind to dental pellicle and
make biofilms. If they existed in planktonic state, saliva would easily wash them away
(Kreth et al. , 2009). Reduced rate of growth also allows bacteria to survive conditions of
nutrient limitation. A biofilm offers an excellent environment for horizontal gene transfer
(Madsen et al. , 2012). Within a biofilm cells can differentiate and show a division of labor
(Kolter et al. , 2015). In some cases different species of biofilms form a mixed biofilm and
perform metabolic functions that are cooperative. The best example of such symbiosis is
the colonization of the oral cavity by Streptococci. During initial stages of colonization,
aerobic or facultatively anaerobic bacteria attach first. This initial colonization creates
an anaerobic microenvironment that provides a niche for the attachment of the anaerobic
bacteria (Ruby & Goldner, 2007). Scientists have considered a biofilm as an analogue of
a multicellular organism (Nikolaev & Plakunov, 2007).
Considering all these factors it is clear that the biofilm lifestyle provides bacteria with
numerous survival advantages in their natural habitats. Although most biofilms in nature
pose no threat to human life, some can be notoriously dangerous to human health and
also cause a huge economic loss as agents of industrial fouling.
1.2. Biofilms in industries
Bacteria tend to form biofilms on any surface with sufficient moisture and supply of
organic material. Microbial biofilms clog water filtration units affecting drinking water
supply, wastewater transport, desalinization units and industrial water-cooling systems.
Biofilms corrode and block pipelines and interfere with oil and gas extraction processes.
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Different mechanisms of biofilm-induced corrosion have been reviewed extensively (Videla,
2001). In the marine shipping industry, biofilms that form on ship hulls lead to corrosion
and cause increased drag, which results into higher consumption of fuel during transport
as well as higher ship hull maintenance costs (Dobretsov et al. , 2013). A wide number
of pathogenic bacteria form biofilms in food processing industries. Certain pathogenic
strains of Escherichia coli are known to be present on apple surfaces, which compromise
the safety of raw materials used in juice processing industries (Cody et al. , 1999). In
total, industrial biofouling and bio-corrosion cause over $200 billion in damage per year
in the USA alone. Bacterial diseases associated with biofilm formation also devastate
agricultural crops. For example, the Gram-negative bacterium Erwinia amylovora causes a
biofilm-induced disease called fireblight on Apple and Pear plants, resulting in multimillion
Euro damage every season (Vrancken et al. , 2013).
1.3. Biofilms in diseases
Bacteria form biofilms in human and animal hosts and cause a wide range of diseases that
are difficult to treat.
1.3.1. Pseudomonas aeruginosa biofilms in cystic fibrosis
patients
The most studied example is that of cystic fibrosis (CF), an autosomal recessive genetic
disorder that affects the lungs, pancreas, liver and intestines. It is caused by a mutation in
the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which results into
dysfunctional release of mucus. Accumulation of mucus in different organs, especially in
the lungs, provides hostile environment for biofilm formation by Pseudomonas aeruginosa.
These biofilms are resistant to conventional antibiotics and the host immune system, and
lead to chronic infection in the majority of CF patients (Davies, 2002). Because of the
severity of the infection, P. aeruginosa biofilm has been a major focus of the research and
a great deal is known about it (Tolker-Nielsen, 2014).
P. aeruginosa is a Gram-negative, rod shaped bacterium found widely in the environment.
It rarely causes infections in healthy individuals; however it can multiply freely in immune-
compromised people. P. aeruginosa has been a model organism to study biofilm formation.
The matrix of P. aeruginosa biofilms contains two major classes of polysaccharides- cap-
sular and aggregative. Capsular polysaccharides decorate the exterior of the cells whereas
aggregative polysaccharides interact with other components of the matrix and impart
structural integrity to the biofilm (Mann & Wozniak, 2012). Alginate is a capsular polysac-
charide, found in mucoid strains of P. aeruginosa, which is composed of β, 1⇒4 linked
residues of L-guluronic acid and D-mannuronic acid (Evans & Linker, 1973). Alginate has
4
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been implicated in persistence and immune evasion (Leid et al. , 2005). Pel and Psl are
aggregative polysaccharides. Psl is a heterogeneous polymer of D-mannose, D-glucose
and L-rhamnose. Overexpression of Psl causes excessive aggregation of cells indicating
that Psl is a main component of the matrix contributing to the structural integrity. Pel
is a polysaccharide of undefined structure. Pel also contributes to the structural integrity
of the biofilm; however, its role is secondary to that of Psl (Colvin et al. , 2012). Apart
from these polysaccharides, the biofilm matrix of P. aeruginosa also contains extracellular
DNA that makes a significant contribution to its structural stability (Allesen-Holm et al.
, 2006). The exceptional resistance of P. aeruginosa biofilms is attributed to immune-
evasive properties of its matrix components and extremely slow-growing state of cells in
the infected CF patient.
P. aeruginosa biofilms have a three dimensional structure consisting of microcolonies
formed in a mushroom-like shape, separated by fluid-filled channels. Cells within the
biofilm communicate with each other through signaling molecules called acyl homoserine
lactones. Presence of this signaling mechanism is essential for maintaining the three-
dimensional structure of the biofilm (Davies et al. , 1998).
1.3.2. Staphylococcus epidermidis biofilms in device-related
infections
Another example of medically relevant biofilms is device-related infection. Intravenous
catheters, peritoneal dialysis catheters, prosthetic heart valves, joint prostheses, cere-
brospinal fluid shunts save lives of millions, but all have intrinsic risk of surface-associated
infections. These infections are highly resistant and difficult to treat. While they do not
lead to any life-threatening disease, the cost of the treatment puts a severe burden on
public health system. The costs related to such treatment amount to $2 million per year
in the USA alone (Otto, 2008).
Staphylococcus epidermidis is a Gram-positive, coccoid bacterium that is commonly found
on the human skin. It does not cause any infections in healthy individuals (Kloos &
Musselwhite, 1975). However, when it gains access to medical implants it causes severe
infections (Von Eiff et al. , 2002). It is one the highly significant pathogen infecting
medical implants. Biofilm formation by S. epidermidis has been studied in detail and
extensive reviews are available (O’gara & Humphreys, 2001; Otto, 2008).
In comparison to S. aureus, virulence factors found in S. epidermidis are few and biofilm
formation is the most important mechanism associated with infection. Staphylococci
produce unique adhesive proteins called MSCRAMMs (Microbial Surface Components
Recognizing Matrix Molecules) that bind to human matrix proteins such as fibrinogen and
fibronectin. SdrG from S. epidermidis is the most studied MSCRAMM. It has been shown
to bind to fibrinogen and it is involved in intercellular adhesion and aggregation. Apart
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from SdrG, other proteins like SdrF, Aap and EmbP are also known to have similar roles.
Another important component of S. epidermidis biofilm matrix is polysaccharide inter-
cellular adhesin (PIA). This is a polymer of β, 1⇒6 linked N-acetyl glucosamine. It is
alternatively referred to as PNAG. The enzymes encoded from the icaABCD operon syn-
thesize PNAG. It is mainly involved in immune evasion and biofilm accumulation. It also
contributes to the architecture of the biofilm (Rohde et al. , 2010). Deletion mutants of
icaABCD genes are unable to form ‘towers’ and ‘mushrooms’ in the biofilm. In spite of be-
ing a significant component of the matrix, in case of some clinical isolates of S. epidermidis,
PIA is not synthesized. The biofilm formation in those isolates is more dependent on the
adhesive protein Aap. Like P. aeruginosa, Staphylococci use quorum-sensing controlled
surfactant peptides called phenol-soluble modulins (PSMs) to maintain the structure of
the biofilm (Yarwood et al. , 2004).
Researchers have reviewed various diseases caused by bacterial biofilms (Costerton et al. ,
1987). Diseases involving biofilms often become chronic and difficult to treat. Researchers
are now studying the exact nature of biofilm infections in order to find ways to treat them
(Bjarnsholt et al. , 2013).
1.4. What makes biofilms stress-resistant?
As noted above, residing in a biofilm confers resistance to many of the stresses incurred in
harsh environments. Being attached and embedded in a slimy material protects the cells
from desiccation and starvation. There are two main hypotheses regarding biofilms’ ex-
ceptional resistance to environmental stress. The first is that the extracellular matrix acts
as a barrier and prevents penetration of antimicrobial agents. The polymeric nature of the
matrix alters diffusion of small molecules within a biofilm (Stewart & William Costerton,
2001). Antimicrobial agents such as superoxides, antibiotics, detergents, surfactants and
immunoglobulins are either blocked, neutralized or diluted to sublethal concentrations be-
fore they reach individual bacterial cells within a biofilm. The second mechanism suggests
that at least some cells in a biofilm exist in a dormant, slow-growing state. While some an-
tibiotics can penetrate the biofilm matrix, they are ineffective against these dormant cells.
Antibiotics require at least some degree of metabolic activity to be effective since they
target such activities to kill the cells. Formation of dormant cells is one of the significant
factors contributing to exceptional resistance of biofilms (Brown et al. , 1990).
1.5. Differential expression of genes in biofilms
The biofilm-lifestyle of bacteria is fundamentally different than the planktonic lifestyle.
The drastic phenotypic changes observed in biofilms led to the hypothesis that physiolog-
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ical modifications involved in transitioning to the biofilm mode of life must be regulated
through changes in gene expression.
The earliest evidence supporting this hypothesis came from gene-fusion studies, which
suggested that the expression of approximately 38% of bacterial genome might be affected
during biofilm formation (Prigent-Combaret et al. , 1999). However, studies based on
DNA-microarray methods indicated that only 5 to 10% of the genome might be expressed
differently during biofilm formation (Schembri et al. , 2003; Ren et al. , 2004). So far such
studies have been performed with E. coli, P. aeruginosa, S. aureus, Bacillus subtlis and
some other bacteria. Researchers have not found any specific pattern of gene expression
that is common to all biofilms.
However, certain trends in gene expression in biofilms observed in different species have
been reviewed (Beloin & Ghigo, 2005). The switch from planktonic to sessile growth
phases requires down-regulation of genes related to motility and up-regulation of genes
encoding adhesive polymers. The metabolic state of cells within a biofilm is similar to
that of cells in stationary phase. Cells in a biofilm show induction of genes related to
stress-response. Every biofilm is perhaps a world of its own, implying a unique pattern
of gene expression. What is true for E. coli biofilms may not be true for P. aeruginosa
biofilms. The pattern of gene expression within a biofilm is variable, both spatially and
temporally. Studying expression of genes in various micro environments within a biofilm
at different intervals of time can be more informative rather than transcriptomic analysis
of the whole biofilm biomass.
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2. Escherichia coli biofilms
E. coli is the most widely studied bacterium. It is a Gram-negative, rod-shaped, facultative
anaerobe that inhabits in the gut of humans and other mammals. Although it is a harmless
commensal, some strains of E. coli have acquired certain virulence attributes, which confer
an ability to colonize other niches and cause a wide spectrum of diseases. Three main
categories of infections caused by pathogenic E. coli are enteric/diarrheal diseases, urinary
tract infection and sepsis/meningitis (Kaper et al. , 2004). Many isolates of E. coli are
able to form biofilms in vivo and in vitro. Due to ease of handling, it has been extensively
used for understanding biofilms. Different events from surface attachment to formation of
a mature biofilm have been reviewed in detail (Beloin et al. , 2008). Since the extracellular
matrix is the most important part of a biofilm, it is described here more in detail.
2.1. E. coli biofilm matrix
The E. coli biofilm matrix predominantly contains exopolysaccharides- cellulose, PGA and
colanic acid. The matrix also contains cellular appendages like flagella, type 1 fimbriae
and proteinaceous curli fibers. These components make the structural scaffold of the
biofilm. It also contains limited amounts of lipopolysaccharides and capsules to a small
extent, which may have an indirect role in biofilm formation. Figure 2.1 shows a schematic
representation of the biofilm matrix of E. coli.
PGA (poly-n-acetyl glucosamine)
PGA is a homopolymer of N-acetyl glucosamine residues connected by β, 1⇒ 6 linkages.
Around 10% of the residues are de-acetylated. This polymer is the same as PNAG found
in Staphylococci. Enzymes encoded by the operon pgaABCD synthesize this polymer.
Among the genes present on the operon, pgaC and pgaD encode inner membrane proteins
responsible for synthesis of the polymer, whereas pgaA and pgaB encode outer membrane
proteins involved in export of the polymer. PGA is primarily cell-associated and localized
at cell poles (Itoh et al. , 2008). The deletion mutant of PGA forms less biofilms (Niba
et al. , 2007). Lack of PGA does not completely abolish the ability of the cells to attach
to a surface. However, it affects the process of transition from temporary to permanent
attachment (Agladze et al. , 2005).
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Figure 2.1. – The biofilm matrix of E. coli. (Figure adapted from Kostakioti et al. (2013))
Cellulose
Cellulose is a homopolysaccharide composed of D-glucopyranose units linked by β-1⇒4
glycosidic bonds. It is expressed from the bcsABZC operon. E. coli harbors the genes
responsible for cellulose synthesis, however, the most common laboratory strain E. coli
K12 is not known to produce cellulose. Certain wild type isolates of E. coli have been
shown to produce cellulose under specific conditions. Co-expression of cellulose with thin
aggregative fimbriae dramatically alters the morphology of the biofilm (Zogaj et al. , 2001).
In short, cellulose is more relevant in three-dimensional structure of the biofilm than initial
attachment of the cells.
Colanic acid
Colanic acid is a negatively charged polymer of glucose, galactose, fucose and glucuronic
acid that forms a protective layer on the bacterial cell under specific conditions. Its syn-
thesis involves 19 genes located in the same cluster named wca. Colanic acid does not
enhance adhesion of bacterial cells to the surface but rather blocks the cell-surface inter-
actions. However, expression of colanic acid is up regulated in mature biofilms, indicating
that its synthesis is involved in shaping the structure of the biofilm (Hanna et al. , 2003).
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Type 1 Fimbriae
Type 1 fimbriae (or pili) are filamentous proteinaceous adhesins commonly expressed by
several strains of E. coli (Sauer et al. , 2000). There are normally 100 to 500 type 1
fimbriae present on a bacterial cell surface. Fimbriae are tubular structures, around 5 to 7
nm in diameter and 0.2 to 2 μm long. They can adhere to various receptor molecules on
eukaryotic cell surface and also to some abiotic surfaces. They are synthesized from the
fimBEAICDFGH operon. Within this operon fimB and fimE encode regulatory proteins;
fimA, fimG, fimF and fimH encode structural proteins of fimbriae and others make proteins
involved in their synthesis. A typical fimbria is a right-handed helical rod composed of
around 1000 FimA residues with a tip made up of the adapter proteins FimG and FimF
and the adhesin FimH (Schilling et al. , 2001). A deletion mutant of fimA is severely
compromised for attachment to surfaces and thus is defective in biofilm formation (Beloin
et al. , 2004).
Curli fibers
Curli fibers are similar to fimbriae in structure and function. They are proteinaceous tubular
structures present on the E. coli cell surface. They are 0.5 to 1 μm long and 6 to 12 nm
in diameter. Curli fibers attach to proteins of the extracellular matrix of human tissues
such as fibronectin, laminin and plasminogen and thus promote attachment of bacterial
cells to different human cells (Nasr et al. , 1996). They also promote biofilm formation
on abiotic surfaces (Uhlich et al. , 2006). Genes involved in curli synthesis are clustered in
the csgBA operon, which encodes curli structural components, and the csgDEFG operon,
which encodes a transcriptional regulator (CsgD) and curli export machinery (CsgE-G).
Expression of curli is cryptic in the most common laboratory strains of E. coli whereas in
other isolates it is under tight transcriptional regulation (Brombacher et al. , 2003).
Flagella
A flagellum is a lash-like extracellular appendage of E. coli that functions as a locomotive
organ. An E. coli cell has around 6 flagella arranged peritrichously over its surface. A
typical flagellum is 15 to 18 nm in diameter and 5 to 10 μm long. Synthesis of a flagellum
involves around 50 genes and is regulated by various factors. Flagella are involved in
attachment of cells to a surface (Giron et al. , 2002), and cells lacking flagella are deficient
in attachment and subsequent biofilm formation (Niba et al. , 2007).
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Cell surface polysaccharides
Besides released polysaccharides like PGA and colanic acid, cell surface-associated polysac-
charides have also been identified to play roles in biofilm formation. Lipopolysaccharide
(LPS) is a glycolipid polymer that constitutes the main component of the outer membrane
of E. coli cell. It is synthesized by the action of more than 50 genes. Mutations affecting
LPS synthesis often affect the ability of E. coli cells to adhere to surfaces (Genevaux et al.
, 1999). However, since defects in LPS synthesis affect type 1 fimbriae expression and
motility, reduced biofilm formation by LPS synthesis mutants could be due to indirect ef-
fects. E. coli cells also possess surface-enveloping structures composed of high molecular
weight capsular polysaccharides that are firmly attached to the cell. They are proven to
be virulence factors and protect the cells from attack by immune cells. Some capsular
polysaccharides are released into the medium and display anti-adhesion activities towards
both Gram-positive and Gram-negative bacteria. These polysaccharides weaken the inter-
actions between cells and surfaces and drastically reduce biofilm formation. They can be
used to prevent attachment of nosocomial pathogens (Valle et al. , 2006).
2.2. Biofilms of different WT strains of E. coli
Several strains of E. coli, that are designated as WT strains are in use in the scientific
community. The strain K-12 was isolated from a diphtheria patient in Palo Alto, California
in the year 1922. This strain was deposited in Stanford University and given the name-
‘K-12’ (Bachmann, 1996). Several other sub-strains were derived from this strain. The
strains MG1655 and W3110, which are derivatives of K-12 are closely related. Recent
whole-genome sequencing of these two strains has revealed that W3110 carries mutations
in eight sights in comparison to MG1655 (Hayashi et al. , 2006). Some lineages of W3110
acquired a mutation in the CDS of rpoS, which resulted in the non-functional Sigma S
transcription factor (Jishage & Ishihama, 1997). Sigma S is a subunit of RNA polymerase,
which transcribes the genes involved in general stress response and secondary metabolism
(Maciag et al. , 2011). This strain, with non-functional Sigma S, is referred to as W3110
in this thesis.
A certain lineage of W3110 is known for having functional Sigma S. This strain is regarded
as W3110RH in this thesis. Derivatives of E. coli K12 do not produce cellulose in spite
of containing genes encoding enzymes required for cellulose biosynthesis (Zogaj et al. ,
2001). Researchers figured out that a single mutation in the bcs operon had resulted in
the lack of production of cellulose. They ‘cured’ this mutation and derived a strain of E.
coli that synthesizes cellulose (Serra et al. , 2013). This strain is regarded as W3110AR
in this thesis.
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2.3. The crsA mutant of E. coli
There are several regulatory processes involved in biofilm formation. CsrA (Carbon Storage
Regulation), for example, regulates several unrelated pathways, including central carbon
metabolism, motility, biofilm formation, virulence, pathogenesis, quorum sensing, and
oxidative stress response etc. (Timmermans & Van Melderen, 2010). It is a 61 amino
acid protein that binds to mRNA and regulates its stability and translation. It acts mostly
negatively by inhibiting the translation of mRNA and thus regulates the pathway post-
transcriptionally (Romeo et al. , 1993). There are two sRNAs called CsrB and CsrC, which
bind and sequester CsrA, thereby inhibiting its activity (Weilbacher et al. , 2003).
The functions of CsrA are essential for survival of the cell. It is not possible to make a
deletion mutant of csrA. However, scientists were able to generate a transposon-insertion
mutant of csrA, which was not only viable but also formed prolific biofilms. The growth
rate of this mutant was the same as that of the wild type, and biofilms made by this mutant
were robust, but normal in appearance. Overexpression of CsrA led to the opposite result,
namely decreased biofilm formation (Jackson et al. , 2002). The effect on biofilm formation
is due to de-repressed synthesis of PGA, a component of the extracellular matrix of E. coli.
CsrA binds to pgaABCD transcript, which is responsible for synthesis of PGA. Binding
of CsrA lowers the translation rate of the pgaABCD transcript resulting in repression of
PGA synthesis (Wang et al. , 2005). The inhibition of translation of pgaABCD by CsrA
is counteracted by McaS. It also binds to the 5’ untranslated region of the pgaABCD
transcript, however, it opens up the secondary structure of mRNA and allows better
binding of the ribosome (Jorgensen et al. , 2013).
CsrA also represses the translation of YcdT and YdeH, which are GGDEF-containing pro-
teins mainly responsible for the synthesis of cyclic-di-GMP (Jonas). Many processes in
the cell that lead to biofilm formation require the second messenger cyclic-di-GMP. In
general, more cyclic-di-GMP implies more likelihood of biofilm formation and vice versa
(Jonas et al. , 2008). By inhibiting the synthesis of cyclic-di-GMP, CsrA reduces the
likelihood of biofilm formation. CsrA is also known to stabilize the mRNA of flhDC, the
master regulator of flagellum biosynthesis, thereby making the cells more motile (Yakhnin
et al. , 2013). From these different findings, it is clear that CsrA regulates the switch
from planktonic to sessile lifestyle. It drives the cell more towards motility and reduces its
chances of acquiring the sessile lifestyle.
The non-lethal mutant version of csrA (E. coli TRMG1655) is defective in its binding
action. Thus, the csrA mutant strain of E. coli exhibits elevated synthesis of PGA and
increased biofilm formation (Romeo et al. , 1993). This mutation mimics the state of the
cell in which the cell is switching to the biofilm lifestyle.
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2.4. Differential regulation of gene expression in E.
coli biofilms
The physiological state of a biofilm is thought to be an outcome of a coordinated pattern of
gene expression. Various studies performed on different species of bacteria have supported
this hypothesis (section 1.5).
So far, 8 such studies have been performed for E. coli biofilms. Schembri and coworkers
studied differential gene expression within exponential phase cultures, stationary phase
cultures, and one-day old biofilms of E. coli grown in flow-chambers. They used DNA
microarray-based technique to quantify the levels of different mRNA molecules present
in the cells. They found that a very small percentage of genes is significantly altered
in biofilms in comparison to other planktonic cultures of either growth phases. They
observed that genes encoding proteins involved in adhesion, such as type 1 fimbriae and
antigen 43 are highly expressed in biofilms. Along with adhesive factors, genes encoding
(putative) transport proteins, putative oxidoreductases and genes associated with heavy
metal resistance were also induced in biofilms. Unfortunately most of the genes that were
significantly altered were not identified and not assigned any definite function (Schembri
et al. , 2003).
Beloin and coworkers studied gene expression in 8-day old mature biofilms grown in a
bioreactor. They observed that the pattern of gene expression in a biofilm is very much
similar to that of a stationary phase culture. Their general observations are summarized
in figure 2.2. They provided evidence that the expression of genes associated with envelop
stress response (psp operon, rpoE and cpx pathways) is a general feature of E. coli
mature biofilms. They performed functional profiling of the identified genes by creating
deletion mutants and observing their effects on biofilm formation. They also constructed
transcriptional reporters of these genes and studied their spatial and temporal pattern of
expression (Beloin et al. , 2004).
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Figure 2.2. – Genes up regulated in biofilms (Beloin et al. , 2004)
Ren and coworkers also performed a similar study on biofilm grown for different intervals
of time. Although they confirmed the induction of type 1 fimbriae, antigen 43 and genes
associated with stress response, they found many other genes significantly altered which
were not in agreement with findings of Schembri and coworkers. They concluded that
the pattern of gene expression depends on the strain, media and conditions of biofilm
formation (Ren et al. , 2004).
Researchers have also realized that the physiological state of cells within a biofilm is highly
heterogeneous. This could be due to differences in availability of oxygen and nutrients in
all parts of a biofilm. These differences are also reflected in the pattern of gene expression.
When cells from a biofilm are harvested for mRNA isolation, this spatial heterogeneity is
not taken into account. This results in poorer understanding of the biofilm-associated
pattern of gene expression.
Besides studying the pattern of gene expression, it is also interesting to look at the genes
essential for biofilm formation. Niba and colleagues screened a collection of single-gene
deletion mutants of E. coli to identify the genes directly involved in biofilm formation (Niba
et al. , 2007). Out of 3985 deletion mutants of non-essential genes that were examined in
this study, 110 were found to result in reduced biofilm formation. The majority of these
110 genes were those involved in flagellar biosynthesis, biogenesis of adhesive structures
like type 1 fimbriae, curli and lipopolysaccharides. As stated by the authors, there could
be other genes involved in biofilm formation, which are required in some other conditions.
Since gene-expression within biofilms is heavily dependent on conditions of growth, further
investigation is required to identify such genes.
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3. Methods of combating biofilms
Due to huge economic losses caused by biofilms and their considerable stress resistance,
combating biofilms is a major outstanding challenge for researchers. As new aspects about
biofilm formation are discovered, novel strategies of combating them are continually being
explored. The following is a brief review of various strategies that researchers have explored
to combat biofilms. These strategies are broadly classified into physicochemical methods,
biochemical methods and biological methods.
3.1. Physicochemical methods
Physicochemical methods involve physical or chemical destruction of biofilms. These meth-
ods are more relevant in industrial settings. The most common methods are treatment with
hot water, detergents, common disinfectants or sonication. Another approach is to modify
surfaces in order prevent attachment of bacteria. For example, electro-polished stainless
steel reduced the attachment of bacteria and subsequent biofilm formation (Arnold &
Bailey, 2000). Coating surfaces with immobilized lysozyme also significantly prevented
the attachment of bacteria (Yuan et al. , 2011). Use of detergents was also employed
in a healthcare setting. Researchers evaluated different detergents for their efficiency to
remove biofilms from endoscopes (Vickery et al. , 2004).
3.2. Biochemical methods
Biochemical methods are those in which a biologically derived compound is used to eradi-
cate biofilms. The mechanism of action of this agent can be specific to a particular biofilm
or a particular stage of biofilm development. Bacteria use quorum sensing to coordinate
communal behaviors such as bioluminescence, virulence and in some cases biofilm forma-
tion (Miller & Bassler, 2001). The most commonly used compounds in quorum sensing are
acyl homoserine lactones (AHLs). Researchers have identified enzymes, which hydrolyze
AHLs and disrupt bacterial communication (Chen et al. , 2013). Such enzymes have been
used to coat surfaces and prevent biofilm formation (Kim et al. , 2014).
As described above, extracellular matrix is probably the major hindrance in the action of
antimicrobial agents. Researchers have shown that lipopeptide biosurfactant produced by
Bacillus licheniformis significantly enhances the efficacy of antibiotics used in killing E. coli
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biofilms (Rivardo et al. , 2009). Micelle-encapsulated antibiotics are reported to kill biofilm
cells (Cheow & Hadinoto, 2014). Some biofilm forming bacteria also secrete enzymes
that can degrade a certain component of the matrix. Such enzymes are necessary for the
turnover of organic material within a biofilm. Researchers have combined conventional
antimicrobial agents with such enzymes to enhance their penetration into the biofilm.
Aminoglycosides administered along with DNAseI and alginate lyase helped is reducing P.
aeruginosa cells in CF patients (Alipour et al. , 2009).
3.3. Biological methods
Biological methods make use of bacteria or phages to attack a biofilm. In nature, several
species of bacteria co-exist. In order to outcompete each other, bacteria produce certain
compounds, which are detrimental to other species. For example, some strains of E. coli
produce colicins, which lyse the cells of other species, however protect the cells of their
own (Cascales et al. , 2007). The early dental plaque colonizer Streptococcus gordonii
secretes proteases that reduce subsequent colonization of S. mutans (Wang et al. , 2011).
Bacteriophages are natural enemies of bacteria. They can also be used to target a biofilm.
The real potential of these abilities of bacteria can be exploited by engineering them in
order to target a specific biofilm and eradicate the biofilm effectively.
Researchers have engineered phages to express a biofilm-degrading enzyme that effectively
kills the biofilm (Lu & Collins, 2007). Phages expressing quorum-quenching enzymes have
been reported to lyse bacterial cells in a biofilm and inhibit the signaling of other bacteria
in the vicinity (Pei & Lamas-Samanamud, 2014). Researchers have designed a ‘pathogen-
sense and kill’ system in which engineered bacteria sense the presence of a target biofilm
through quorum sensing system and secrete an anti-biofilm compound that eventually
destroys the target biofilm (Hwang et al. , 2013).
The choice of the method depends on the kind of organism and location of a biofilm.
Physicochemical methods are more relevant to industrial settings whereas biochemical
methods are relevant in treating diseases. These methods do have some advantages
in their respective applications; however, none is proven to be the most efficient and
cost effective method. Biological methods in which phages or bacteria are engineered to
disrupt biofilms are comparatively new and still under trials for actual use. However, they
do offer certain advantages over physical and chemical methods. These methods mainly
exploit a signal transduction pathways underlying biofilm formation or dispersal. They can
function without adding an external inducing agent. Their action can be specific as well
as versatile at the same time. Biological methods can be combined with biochemical or
physicochemical methods to have better results. With existing strategies having various
limitations, biological methods are offering a novel and efficient way to combat biofilms.
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3.4. Matrix-degrading enzymes
Many bacteria are known to possess secreted enzymes in their biofilm matrix. These
enzymes degrade polymeric substances in the biofilm matrix. They are involved in recycling
of matrix components and thus maintain the dynamic nature of the biofilm (Kaplan, 2014).
Since they are enzymes produced by bacteria themselves, they are non-toxic, synthesized
in a simple manner, can be expressed in a bacterial host and readily secreted out of the
cells. These properties of matrix-degrading enzymes make them compatible with biological
methods of biofilm disruption. Researchers have identified therapeutic potential of matrix-
disrupting enzymes (Kaplan, 2009) and also successfully shown that they can be efficient
in disrupting biofilms under experimental setting.
The extracellular matrix constitutes 90% of the biomass of a biofilm and provides the
structural scaffold on which the biofilm forms. The matrix also retains water and nutrients
and prevents desiccation of the biofilm. It acts as a barrier to antimicrobial agents.
Thus, it is the most essential aspect of biofilms’ existence. Matrix-degrading enzymes are
mostly peptidases, glycosidases or deoxyribonucleases, which respectively target proteins,
carbohydrates, and DNA present in the biofilm matrix. Degradation of components of the
matrix leads to loss of the structural scaffold and eventual dispersal of the biofilm. There is
no universal enzyme, which can disperse all kinds of biofilms. However, if a certain enzyme
is able to degrade the most important component of a biofilm, it is likely to successfully
disperse that biofilm. For example, alginate lyase is able to disperse P. aeruginosa biofilm
by degrading alginate in its matrix (Boyd & Chakrabarty, 1994). SPRE (surface-protein-
releasing enzyme) can disperse the biofilm of S. mutans by degrading salivary receptor
P1, which is responsible for attachment of cells to the tooth surface (Lee et al. , 1996).
Dispersin B is able to disperse biofilms of wide range of bacteria by degrading poly-N-
acetyl glucosamine (PGA) in their matrix (Itoh et al. , 2005). Researchers have identified
several such enzymes, which are either specific to a particular biofilm or effective against a
wide range of biofilms. Due to their ease of expression in a bacterial host and effectiveness
against biofilms, matrix-degrading enzymes are suitable anti-biofilm candidates.
3.5. Dispersin B
Among various matrix-degrading enzymes discovered so far, Dispersin B has drawn a
perhaps the most attention. Dispersin B is an enzyme isolated from Actinobacter acti-
nomycetemcomitans. This bacterium is Gram-negative, non-motile coccobacillus that
colonizes the human oral cavity. It causes localized juvenile periodontitis, a severe form
of periodontal disease that affects adolescents. Biofilms of this bacterium show a ubiqui-
tous phenomenon of dispersal and formation of new biofilms in other locations. The cells
secrete the enzyme, Dispersin B, which degrades the extracellular matrix and helps in the
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dispersal of the biofilm (Kaplan et al. , 2003).
Dispersin B is a hexosaminidase and belongs to a family of glycosyl hydrolases. It hy-
drolyzes the β, 1⇒6 linkage of poly-N acetyl glucosamine (PGA) of bacterial extracellular
matrix (Itoh et al. , 2005). The 40 kDa enzyme is 361 amino acids long and has a single
domain which can be divided into major substructures. The major substructure is a TIM-
barrel that can be further divided into minor substructures (Ramasubbu et al. , 2005). The
active site is a large cavity in the center of bowl-shaped enzyme and contains Asp184,
Glu183 and Glu322 as most conserved residues. The mechanism of action is similar to
that of other glycosyl hydrolases. It cleaves terminal monosaccharide residues from the
non-reducing end of the polymer (Manuel et al. , 2007).
The activity of the enzyme can be measured using chromogenic substrates (Chibba et al.
, 2011). The most widely used substrate is 4-Nitrophenyl N-acetyl-β-D-glucosaminide
(NP-GlcNAc) (Shibata & Yagi, 1996). This substrate mimics the β, 1⇒6 linkage found in
PGA. Upon action of the enzyme 4-nitrophenoxide is released as a product, which can be
quantified by reading absorbance at 400 nm. Figure 3.1 shows the structures of Dispersin
B, NP-GlcNAc and PGA.
Figure 3.1. – A. Structure of Dispersin B (PDB ID 1YHT, Ramasubbu et al. (2005)), B. Structure
of NP-GlcNAc, C. Structure of PGA
PGA is found in many species of Gram-positive and Gram-negative bacteria such as E. coli,
S. epidermidis, S. aureus, Yersinia pestis, P. fluorscense, Bordetella spp., Xanthomonas
spp., and others. The biofilm-disrupting action of Dispersin B has been demonstrated on
some of these species. Thus, it is possible to have widespread applications of Dispersin B
as a biofilm-disrupting agent.
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4. Signaling pathways in bacteria
Biological methods of combating biofilms involve engineering existing signal transduction
pathways in such a way that the anti-biofilm agent is synthesized in response to a biofilm.
Following is a description of some signaling pathways related to the components of E. coli
biofilm matrix.
4.1. N-acetyl glucosamine and its metabolism in E.
coli
N-acetyl glucosamine is a constituent of PGA, which is an important component of the
biofilm matrix of E. coli. It is also found in various other Gram-positive and Gram-negative
bacteria.
N-acetyl glucosamine is a derivative of glucose. It has an acetylamine residue attached
to C-2 of its glucopyranose ring. It can make different forms of glycosidic linkages with
other sugar molecules and become a part of a polymer. It is an important constituent of
bacterial cell wall, which is made up of peptidoglycan. NAG makes β, 1⇒4 glycosidic bond
with N-acetyl muramic acid to make the tough and insoluble backbone of peptidoglycan.
As stated above, NAG is also a part of chitin, the most abundant polysaccharide in the
marine habitat. Chitin is found in fungal cell walls, crustaceans’ exoskeleton and mollusk
shells. It is a polymer of NAG residues connected by β, 1⇒4 linkage.
NAG is an important metabolite for E. coli. It is not just an excellent source of car-
bon and nitrogen but also an important constituent of the cell wall and cell membrane.
There are many players involved in uptake, catabolism and synthesis of NAG. Two diver-
gent operons, nagE and nagBACD encode enzymes involved in uptake and catabolism
of NAG (Plumbridge, 1991). The gene nagE codes for the enzyme IInag, which is a
phosphoenolpyruvate (PEP)-dependent permease involved in uptake of NAG. It belongs
to the functional superfamily of phosphotransferase system (PTS) sugar transporters. It
is located in the inner membrane and transports NAG inside the cell, at the same time
phosphorylates it to N-acetyl glucosamine-6-phosphate. NagE transports NAG with a low
micromolar affinity, however, plays a significant role in peptidoglycan recycling. The genes
nagA and nagB encode catabolic enzymes. NagA is N-acetyl glucosamine-6-phosphate
deacetylase, which catalyzes the first step of catabolism of NAG. NagB is glucosamine-
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6-phosphate deaminase, which catalyzes the second step of NAG catabolism. The action
of NagB produces ammonia and fructose-6-phosphate, which can enter glycolysis directly.
Deletion mutants of nagA or nagB are unable to survive on NAG as a sole source of
carbon. NagC is a DNA-binding transcriptional dual regulator that binds to the inter-
genic region of nagE and nagB (figure 4.1). The main inducer of NagC is N-acetyl
glucosamine-6-phosphate. NagC is displaced from DNA upon interacting with N-acetyl
glucosamine-6-phosphate. The binding of NagC requires formation of a loop of DNA,
so that it binds to two symmetric operator elements at the same time and regulates the
expression from both nagE and nagBACD operons (Plumbridge & Kolb, 1998). Apart
from NagE, ManX also transports NAG, which is a PTS transporter and functions in a
similar way as that of NagE. NagC also binds to upstream region of manX and de-represses
manXYZ operon upon binding to N-acetyl glucosamine. NagC binds to several other sites
on DNA regulating the expression of many operons.
Figure 4.1. – Organization of the nagE/BACD operon in E. coli (adapted from Plumbridge (1991))
The major source NAG entering the cell is hydrolyzed peptidoglycan. Recycling of pep-
tidoglycan is a routine process that the cell undergoes as it grows and divides. There
are several enzymes in the periplasmic space, which hydrolyze peptidoglycan into various
intermediate products such as anhydromurapeptides, amino sugars and peptides. The
oligopeptide transporter Opp takes up peptides. NagE and other PTS transporters take
up amino sugars and AmpG takes up anhydromurapeptides. NagE is responsible for only
50% of N-acetyl glucosamine-6-phosphate generated in the cell. The remaining 50%
comes from catabolism of anhydromurapeptides. Enzymes like NagZ, AnmK, MurQ and
NagK carry out different steps to generate N-acetyl glucosamine-6-phosphate, which is
further catabolized by NagB and NagA (Park & Uehara, 2008).
In addition to catabolizing NAG E. coli can also synthesize NAG from other sugars. The
genes glmU, glmS, and glmM encode for enzymes required for NAG synthesis. Out of
these genes, glmU and glmS are located in the same operon, whereas glmM is located else-
where. GlmS is L-glutamine fructose-6-phosphate aminotransferase, which transfers amino
group from glutamate to fructose-6-phosphate resulting in formation of glucosamine-6-
phosphate and glutamate. This activity is antagonistic to that of NagB. This is the
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first step in hexosamine synthesis. GlmM is phosphoglucosamine mutase, which converts
glucosamine-6-phosphate into glucosamine-1-phosphate. GlmU is a fused enzyme with two
catalytic activities, glucosamine-1-phosphate acetyl transferase and N-acetyl glucosamine-
1-phosphate uridyltransferase. The former activity adds acetyl group to glucosamine-1-
phosphate and the latter adds UDP moiety to it resulting in the formation of UDP-N-acetyl
glucosamine-1-phosphate. Uridylated NAG is further used in synthesis of peptidoglycan
and lipoproteins. The expression of the glmUS operon is regulated by NagC. However, in
this case NagC acts as an activator. In the absence of N-acetyl glucosamine-6-phosphate,
NagC binds to upstream sequence of glmU and activates its transcription. Upon binding
to N-acetyl glucosamine-6-phosphate, NagC is unable to bind to DNA and the transcrip-
tion of glmUS falls by 5 fold (Plumbridge, 1995). Figure 4.2 describes metabolism of NAG
in a concise manner.
Figure 4.2. – Pathways of NAG metabolism in E. coli (adapted from Uehara & Park (2004))
4.2. Chemotaxis in E. coli
NAG is not just a metabolite but also a chemoattractant. E. coli cells are able to move
towards NAG through a phenomenon termed as chemotaxis. Chemotaxis is movement of
an organism in response to a chemical stimulus. Many prokaryotes, single celled eukaryotes
and certain cells in multicellular organisms exhibit this phenomenon. For bacteria, it is
important to move towards a compound that can be taken up as food or to move away
from a compound that can be dangerous. Bacterial chemotaxis is one of the most studied
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signal transduction pathways. Due to its relative simplicity and modularity it is amenable
to manipulations. Chemotaxis can be combined with other signaling pathways to make
the engineered bacterium more efficient in its action. Chemotaxis in E. coli has been
reviewed in great detail (Baker et al. , 2006).
4.2.1. Components of the chemotactic pathway
The pathway of chemotaxis in E. coli consists of two important sets of players, transmem-
brane chemoreceptors that sense the chemical stimulus in the environment, intracellular
proteins that relay the signal to the flagella and the flagellum (one or many) along with
motor proteins that drive flagellar rotation. Chemoreceptors are transmembrane proteins
with a highly variable periplasmic sensing domain and a well conserved intracellular sig-
naling domain. In E. coli there are 5 types of chemoreceptors, Tar, Tsr, Tap, Trg and Aer.
They exist in higher-order array at one or both the cell poles. They are termed as methyl-
accepting chemotaxis proteins (MCPs) due to their ability to become methylated. MCPs
are responsible for sensing the chemical stimulus in the environment. At the signaling do-
main of an MCP lies a complex of intracellular proteins including CheA and CheW. CheA
is a typical Histidine Kinase, which autophosphorylates and transfers the phosphate group
to a Response Regulator CheY. CheW provides a physical coupling of CheA and MCPs
and mediates the phosphotransfer between CheA and CheY. CheY is a typical response
regulatory, which contains a phosphorylation domain and motor protein-binding domain
(instead of a DNA-binding domain present in most response regulators). CheY interacts
with motor proteins and influences their direction of rotation. CheZ is an intracellular
protein that has phosphatase activity. It dephosphorylates CheY and maintains its level
at a steady state. CheR is another intracellular protein located at the signaling domain of
MCPs, which methylates glutamate side chains of an MCP. CheB counteracts CheR by
de-methylating an MCP.
4.2.2. Signal transduction in chemotaxis
The process of signal transduction in chemotaxis has been reviewed extensively (Eisen-
bach, 1996; Bren & Eisenbach, 2000; Falke et al. , 1997). Figure 4.3 describes how
transduction of signal during chemotaxis takes place. In the absence of any attractant,
the activity of CheA is stimulated, increasing the phosphotransfer rate from CheA to
CheY. Phosphorylated CheY has a lower affinity to CheA and higher affinity to FliM, a
component of the motor protein complex. Thus, it dissociates from CheA and binds to
FliM, changing its direction of rotation from counter-clockwise to clockwise. When the
flagellar motor is rotating counter-clockwise, all flagella coalesce into a bundle, which
propels the cell forward (run). Changing the direction of rotation causes the bundle to
disperse and the cell to tumble. The movement of a cell is a random walk made up of
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alternating runs and tumbles. CheZ prevents over-accumulation of CheY-P by dephos-
phorylating it and thus maintains its steady-state level generating a random walk. Once
an attractant compound binds to the periplasmic sensing domain of an MCP, it undergoes
a conformational change and inhibits the kinase activity of CheA. This lowers the rate of
phosphotransfer to CheY and drops the levels of CheY-P. This results in lower frequency
of tumbling as the cell moves towards higher concentration of the attractant. Adaptive
regulation is necessary to prevent an MCP from saturating and enable it to respond to
increasing concentration of the attractant. CheR and CheB carry out this adaptation.
CheR is a constitutive enzyme that methylates glutamine side chains of an MCP through
the use of S-adenosylmethionine. Methylation enhances the kinase activity of CheA. At a
steady state, CheA phosphorylates CheB along with CheY. CheB-P counteracts CheR by
demethylating the MCP. Thus, kinase activity of CheA is maintained. Upon binding of
the attractant to the MCP, kinase activity of CheA is inhibited leading to fall in level of
CheB-P. This lowers demethylation and the activity of CheR improves the kinase activity
of CheA, thereby resetting the kinase to its basal level. This enables the kinase to respond
to increasing concentration of the attractant.
Figure 4.3. – The pathway of chemotaxis in E. coli (figure adapted from the PhD thesis of David
Kenter, 2010)
4.2.3. PTS-mediated chemotaxis
Apart from this MCP-dependent pathway, there exists an alternative receptor-independent
chemotactic pathway that operates through phosphoenolpyruvate sugar phosphotrans-
ferase systems (PTS). Mechanistic details of this pathway have been explored in great
detail (Lux et al. , 1995, 1999; Neumann et al. , 2012). A typical PTS involves a mem-
brane bound transporter called Enzyme II, and intracellular proteins Enzyme I and HPr.
Enzyme II takes up the sugar from the environment while phosphorylating it. Every sugar
is transported through its specific transporter. Enzyme II can be a single multi-domain
protein or a group of small proteins. The phosphate group used in this process is re-
ceived from a relay of phosphate carried out by Enzyme I and HPr. Enzyme I (encoded
by ptsG ) is a PEP-dependent histidine kinase, which takes up the phosphate group from
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phosphoenolpyruvate. It transfers the phosphate group reversibly to HPr, a phosphohis-
tidine carrier protein, which eventually transfers it to Enzyme II for sugar uptake. There
are 15 such PTSs in E. coli, Enzyme I and HPr being common to all. Several sugars are
taken up though these systems. E. coli exhibits chemotaxis to these sugars since they act
as carbon sources. Enzyme I, in its unphosphorylated form binds to CheA and inhibits
its kinase activity. This effect is the same as that of an attractant compound binding to
the MCP. With increasing concentration of the sugar, levels of unphosphorylated Enzyme
I also increase and cause the cell to move with less frequent tumbles. This results in
chemotaxis of the cell towards the sugar. As stated earlier, the E. coli cell internalizes
NAG through PTS. Thus, the chemotactic pathway for NAG is likely to be through the
PTS. Figure 4.4 shows a schematic of the PTS-mediated chemotaxis pathway.
Figure 4.4. – The pathway of PTS-mediated chemotaxis in E. coli (figure adapted from Neumann
et al. (2012))
4.3. Quorum sensing in S. epidermidis
Quorum sensing is a system of stimuli and responses correlated to the population density.
Many bacteria use this system to coordinate the gene expression according to the density
of their local population. Bacteria regulate a diverse array of physiological functions such
as motility, sporulation, virulence, conjugation, biofilm formation and many others through
the system of quorum sensing (Miller & Bassler, 2001).
There is a single quorum sensing system found in S. epidermidis, which is encoded by agr
(accessory gene regulator) operon (figure 4.5). Much of the knowledge of this system
in S. epidermidis is based on that in S. aureus (Thoendel et al. , 2011). The agr locus
consists of two operons RNAII and RNAIII. The operon RNAII encodes 4 ORFs agrB,
agrD, agrC, and agrA. AgrD is a peptide that is processed and exported by AgrB. The
secreted peptide is 8 amino acids long and shows cyclization at the C-terminus (Otto
1998). This peptide acts as signaling molecule. AgrC is a histidine kinase located at the
cell membrane. It senses the AIP in the environment and phosphorylates the response
regulator AgrA. AgrA then binds to the intergenic region between RNAII and RNAIII and
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activates the expression of both the operons. Activation of RNAII leads to more synthesis
of AIP. The transcription product of RNAIII has a dual role. It mediates the synthesis
of deltatoxin and also functions as a regulatory RNA that alters the expression of many
other genes.
Figure 4.5. – The agr quorum-sensing system of S. epidermidis (figure adapted from Thoendel
et al. (2011))
4.4. Protein secretion systems in E. coli
Another important aspect of an engineered bacterial system is its ability to secrete a
protein of interest. Secretion makes the protein available in the extracellular space for its
intended action. Thus, it is necessary to take an overview of protein secretion systems in
E. coli.
E. coli possesses several different kinds of protein secretion systems. For any protein to be
secreted out of the cell, it has to pass through three barriers- inner membrane, periplasm
and outer membrane. Depending on the mechanism by which the proteins are transported
through these barriers, secretion systems have been classified into 6 different types. The
structure, assembly and the mechanism of these systems have been explored well in detail
(Gerlach & Hensel, 2007; Kostakioti et al. , 2005).
4.4.1. T2SS and the general secretory pathway
Among various secretion systems present in E. coli, the type II secretion system (T2SS)
is described here. T2SS is the terminal step of the general secretion pathway (steps
D1 and D2 in figure 4.6). It consists of multimeric porin complexes in the outer mem-
brane. For proteins to cross the inner membrane, there are two major types of pathways-
Sec-dependent and Sec-independent (TAT). There is an important subtype of the Sec-
dependent pathway, which is called SRP pathway. These pathways together constitute
the general secretion pathway. Figure 4.6 is a schematic representation of the general
secretion pathway in E. coli.
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Figure 4.6. – The general secretory pathway of protein secretion in E. coli (figure adapted from
Mergulhão et al. (2005))
In the Sec-dependent pathway, a protein to be secreted is synthesized in the cytoplasm
in unfolded or partially folded form. SecA recognizes the preprotein while binding to its
N-terminal signal sequence. SecB is a chaperon that maintains it in the unfolded state
(step A1 in figure 4.6). It is then brought to SecYEG export complex located in the inner
membrane (step A2 in figure 4.6). The preprotein is then exported into the periplasm with
the help of many other proteins. Chaperons present in the periplasm help in folding the
preprotein into a functional form. In SRP pathway, a signal recognition particle (SRP),
similar to the one in eukaryotes, recognizes the preprotein and brings it to SecYEG complex
independent of SecA (steps B1 and B2 in figure 4.6). The preprotein is exported out of
the inner membrane in a co-translational manner (Beckwith, 2013).
In the Sec-independent pathway, also known as Twin Arginine Translocation (TAT) path-
way, proteins are exported in folded form. The protein to be exported is recognized by
TatB/TatC complex and other components of TAT pathway assemble at the inner mem-
brane to form a translocation pore. The protein is then exported through this pore (steps
C1 and C2 in figure 4.6). The TAT export complex has extraordinary structural flexibility.
Proteins exported through TAT system vary greatly in size, structure and function (Lee
et al. , 2006).
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4.4.2. Secretion of heterologous proteins
Engineering E. coli cells to secrete heterologous proteins into the surrounding medium
offers several advantages over intracellular production. Proteins secreted in the medium
can be easily purified due to reduced contamination by other intracellular proteins. The
process of secretion also saves the heterologous protein from the action of intracellular pro-
teases. Researchers have explored various strategies to improve secretion of heterologous
proteins by E. coli and they have been reviewed (Yoon et al. , 2010).
Among all the explored strategies, fusing the heterologous protein to a signal sequence is
the easiest strategy. The secretions signal sequences of several proteins such as OmpA,
PelB, PhoA, YebF, FlgM etc. have been tested so far (Mergulhão et al. , 2005). The secre-
tion signal sequence of OmpA has been used extensively for export of many heterologous
proteins (Takahara et al. , 1985; Guisez et al. , 1998).
4.4.3. The protein OmpA and its secretion signal
OmpA is a non-specific diffusion channel located in the outer membrane of E. coli, allowing
various solutes to pass through. It is the most abundant protein in the outer membrane.
It is a multifaceted protein that functions as a porin and an adhesin; it is exploited
by bacteriophages for attachment, it mediates F-factor dependent conjugation and is
also involved in maintaining morphology of the outer membrane (Smith et al. , 2007a).
It is 325 amino acids long and first 171 residues form a β-barrel structure with eight
amphipathic antiparallel β strands connected by four long loops at the outer surface of
the membrane and three at the periplasmic side (Reusch, 2012). The C-terminal portion
of the protein resides in the periplasm and perhaps interacts with peptidoglycan (De Mot
& Vanderleyden, 1994).
OmpA is exported through the inner membrane via Sec-dependent system. The periplas-
mic chaperon protein Skp maintains it in unfolded state. It is then incorporated into the
phospholipid bilayer of the outer membrane with the help of the Bam outer membrane
assembly protein complex (Bulieris et al. , 2003). The first 21 amino acid residues at
the N-terminus of OmpA serve as a secretion signal (Movva et al. , 1980). This stretch
of 21 amino acids possesses all the features of a typical secretion signal. It has 2 lysine
residues at the N-terminus imparting basic character, a long middle region of hydrophobic
residues and a cleavage site around alanine residue. This sequence of 21 amino acids can
be fused to heterologous proteins to drive their secretion out of the cell. Figure 4.7 shows
the sequence of the secretion signal and the topology of the OmpA protein.
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Figure 4.7. – The OmpA protein A. Topology of the protein (Smith et al. (2007b)), B. Sequence
of the secretion signal of OmpA (Movva et al. (1980))
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5. Aims of the current work
The objective of this project is to develop a novel and efficient strategy to combat bac-
terial biofilms. Figure 5.1 describes the general strategy of this project. The engineered
bacterium, regarded as the ’killer ’ detects the presence of a target biofilm, regarded as
the ‘victim’ by sensing a compound specific to the ‘victim’. In response to this detection,
the ‘killer ’ starts synthesizing an anti-biofilm compound, regarded as the ‘weapon’. This
‘weapon’ is then secreted and the ‘victim’ is disrupted.
To materialize the whole concept, one must divide the objective into different steps. The
first step will be to select the ‘killer ’ and the ‘victim’. The next step will be to select the
‘weapon’ expressed by the ‘killer ’ that efficiently disrupts the biofilm of the ‘victim’. The
final and the most important step will be to select a suitable signaling pathway through
which sensing (‘victim’ detection) and response (‘weapon’ deployment) can be combined.
Figure 5.1. – The strategy of engineering bacteria to disrupt a bacterial biofilm
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6. Materials
6.1. Buffers
Buffers used in this study are listed in table 6.1.
Buffer Composition
Phosphate buffer 1.742 g K2HPO4
1.361 g KH2PO4
Add ddH2O to a total volume of 1 l and adjust pH to 7
Tethering buffer 1.742 g K2HPO4
1.361 g KH2PO4
37.2 mg EDTA
10 μl 100 μM L-Methionine
Add ddH2O to a total volume of 1 l and adjust pH to 7
PNAG buffer 8.77 g NaCl
1.21 g TRIS base
Add ddH2O to a total volume of 1 l and adjust pH to 7
TSS buffer 5 g PEG 8000
0.3 g MgCl2.6H2O
2.5 ml DMSO
Add LB medium to a total volume of 50 ml and sterilize by
filtration
Table 6.1. – Buffers used in this study
6.2. Media
Media used for growing bacteria are listed in table 6.2.
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Medium Composition
LB (Luria Bertani) medium 10 g Bacto tryptone
5 g Bacto yeast extract
5 g NaCl
Add ddH2O to a total volume of 1 l and adjust pH to 7
TB (Tryptone broth) 10 g Bacto tryptone
5 g NaCl
Add ddH2O to a total volume of 1 l and adjust pH to 7
TSB (Tryptic soy broth) 30 g dehydrated TSB (Sigma-Aldrich)
Add ddH2O to a total volume of 1 l and adjust pH to 7
5X M9 salts 64 g Na2HPO4.7H2O
15 g KH2PO4
2.5 g NaCl
5 g NH4Cl
Add ddH2O to a total volume of 1 l and adjust pH to 7
M9 minimal medium 200 ml 5X M9 salts
10 ml 20% Glycerol
1 ml 1M MgSO4
0.5 ml 0.1 M CaCl2
1 ml 10% Casein hydrolysate
Add ddH2O to a total volume of 1 l and adjust pH to 7
5X minimal A salts 52.5 g K2HPO4
22.5 g KH2PO4
5 g (NH4)2SO4
2.5 g Na citrate
Add ddH2O to a total volume of 1 l and adjust pH to 7
Minimal medium A agar 200 ml 5X Minimal A salts
10 ml 20% Glycerol
1 ml 1M MgSO4
8 ml 5mg/ml amino acid mix (L- methionine, L- cysteine,
L- threonine, L- histidine)
2 ml 50 mg/ml thiamine
500 ml 0.45% agar (dissolved in sterile ddH2O)
Add ddH2O to a total volume of 1 l and pour into Petri
plates
Table 6.2. – Media used in this study
To make solid media, agar was added to the respective medium to make a final concen-
tration of 1.5%. Unless and otherwise stated, all media were sterilized by autoclaving at
15 psi, 121-124 °C for 15-20 minutes.
6.3. Antibiotics
Antibiotics used in this study are mentioned in table 6.3. All antibiotics were purchased
from Sigma-Aldrich. Stock solutions were prepared in suitable solvents and stored at -20
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°C. Stock solution was thawed and diluted to working concentration as per the requirement.
Antibiotic Stock
concentration
Working
concentration
Solvent
Ampicillin 100 mg/ml 100 μg/ml ddH2O
Kanamycin 50 mg/ml 50 μg/ml ddH2O
Chloramphenicol 100 mg/ml 50 μg/ml Ethanol
Table 6.3. – Antibiotics used in this study
6.4. Reagents used in molecular biology techniques
Enzymes used for amplification and manipulation of DNA, were purchased from New
England Biolabs, Thermo Scientific, and Invitrogen. Size standards for DNA, RNA and
proteins and dyes for their visualization were purchased from Invitrogen.
6.5. Kits
Routine protocols of molecular biology such as plasmid isolation, agarose gel extraction
and purification, RNA isolation and also protein purification were performed with the help
of commercially available kits. Table 6.4 enlists the kits that were used in this study.
Name of the kit Application Company
GeneJET Plasmid mini-prep
kit Plasmid isolation Thermo Scientific
GeneJET Gel extraction kit Extraction of DNA fragment
from agarose gel and its
purification
Thermo Scientific
GeneJET PCR purification
kit Purification of amplified DNA
from PCR reaction mixture
Thermo Scientific
Universal RNA extraction kit Isolation of total RNA Roboklon
Protino NI-IDA 2000 packed
columns Purification of His-tagged
proteins
Machery-Nagel
Table 6.4. – Kits used in this study
6.6. Softwares
Following is the list of softwares used for different analyses and visualization (Table 6.5 ).
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Name of the
software
Application
Serial cloner In-silico DNA manipulation
ArrayStar by DNAStar Analysis of RNA-seq data
Kaleidagraph Graphical representation of
quantitative data
FlowJo Analysis of flow-cytometry
data
Table 6.5. – List of softwares used in this study
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7. Methods
7.1. Growth and cultivation of bacteria
Bacteria were mostly grown in Luria Bertani (LB) medium supplemented with appropriate
antibiotics. In some cases, Tryptone broth or M9 minimal medium was used. For long-term
storage, overnight culture of a bacterial strain was spun down at 10000 rpm in a table-top
centrifuge and re-suspended in LB mixed with 20% Glycerol. Afterwards it was stored
at -80 °C. For short-term storage, bacterial strains were streaked out on LB-agar plate
(containing appropriate antibiotics), grown for 16 to 20 hours at 37 °C and then stored at
4 °C. For performing an experiment, a tiny portion of a bacterial colony from an LB-agar
plate or a little frozen cell mass scratched off from the frozen bacterial glycerol-stock was
inoculated in LB medium and grown overnight (12 to 16 hours) at 37 °C on a culture-
wheel. This overnight culture was used for the experiments as described in respective
protocols.
7.2. Molecular biology techniques
Molecular biology techniques used in this study were performed using standard protocols as
described in the book ‘Molecular Cloning- a laboratory manual’ (Green, 2012). Manufac-
turer’s instructions were followed wherever commercially available kits were used. Making
of certain constructs used in this study is further described more in the detail.
7.2.1. Plasmid isolation
The isolation of plasmid DNA was performed using GeneJET plasmid mini-prep kit (Thermo
Scientific).
7.2.2. Polymerase Chain Reaction (PCR)
Polymerase chain reaction (PCR) was used to amplify the desired fragment of DNA from
genomic DNA or plasmid DNA as a template. The enzymes used for amplification were
purchased from Thermo Scientific. ‘Phusion High Fidelity DNA Polymerase’ (catalog
number) was mainly used amplifying for fragments larger than 1000 bp. and T4 DNA
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Polymerase (for DNA fragments smaller than 1000 bp) both purchased from Thermo
Scientific. PCR was also used to fuse two different fragments of DNA into one fragment.
The technique is described as Overlap Extension PCR (Horton et al. , 1989). After setting
the reaction mixture, amplification was carried out in peqSTAR 96X Thermocycler. A
variant of PCR, called colony-PCR was used to screen for correct recombinants. A small
portion of the bacterial colony was used instead of a genomic or plasmid DNA as a template
and amplification was carried out as described above. Successful amplification of the DNA
fragment was confirmed by visualizing the product of the reaction on an agarose gel. The
reaction mixture was purified using GeneJET PCR purification kit to purify the amplified
DNA for further use.
7.2.3. Restriction digestion
DNA fragments or plasmids were digested by restriction endonucleases purchased from
New England Biolabs. Manufacturer’s protocol was followed to set up the digestion reac-
tion. The digested DNA fragment or plasmid was purified with the help of GeneJET Gel
Extraction kit or GeneJET PCR-purification kit, both purchased from Thermo Scientific.
7.2.4. Ligation
Digested DNA fragments were ligated into digested plasmids (cloning vectors) by using
T4 DNA Ligase enzyme purchased from Thermo Scientific. A ligation mixture was set in
such a way that insert and vector were in 3:1 or 9:1 ratio and the total amount of DNA
was at least 50 ng in the total volume of 10 μl. The mixture was incubated at room
temperature for around 10 minutes and used for transformation.
7.2.5. Preparation of chemically competent E. coli cells
CaCl2 method E. coli cells were grown to OD600 of approximately 0.6. The cells were
spun down (10 min, 4000 rpm, 4 °C) and re-suspended in 0.1 M MgCl2 so that the volume
is half of the original culture. The cells were incubated on ice for 30 min and spun down
again under the same conditions. Re-suspension was carried out with 0.1 M CaCl2 so
that the volume remains the same as previous step. The cells were incubated on ice for
5 minutes and spun down again under the same conditions. The pellet was re-suspended
in 0.1 M CaCl2 with 18% glycerol in such a way that the total volume is 1/10th of the
original culture. This re-suspension was directly used for transformation or frozen using
liquid nitrogen and stored at -80 °C.
TSS method E. coli cells were grown to OD600 of approximately 0.6. The cells were
spun down at maximum speed in a tabletop centrifuge. The pellet was re-suspended in
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TSS buffer so that the volume is 1/10th of the original culture. The re-suspension was
incubated on ice for at least 30 minutes and used for transformation. Alternatively, it was
frozen using liquid nitrogen and stored at -80 °C for further use.
7.2.6. Transformation
To introduce plasmids into E. coli cells, 100 μl of chemically competent cells were thawed
on ice. The desired plasmid or a ligation mixture was mixed with the competent cells and
incubated on ice for 30 minutes. The mixture was given a heat shock at 42 °C for 45
seconds followed by incubation on ice for 2-3 minutes. The cells were allowed recover by
adding pre-warmed LB medium and shaking at 37 °C for approximately one hour. This
mixture was then spun down at high speed in a tabletop centrifuge and plated on an
LB-agar plate containing respective antibiotic. The plate was incubated at 37 °C for 16
to 20 hours for colonies to appear. Colonies observed on this plate were re-streaked on
a fresh LB-agar plate. These re-streaked colonies were used to perform colony-PCR for
screening for the correct recombinant.
7.2.7. Agarose gel electrophoresis
Mixtures containing DNA to be visualized were mixed with 6X DNA loading dye (pur-
chased from Thermo Scientific) and loaded on 1% agarose (in TAE buffer) gel slab mixed
with Midori Green (purchased from Nippon Genetics Europe GmBh). Midori Green is a
fluorescent nucleic acid stain, which shows strong fluorescence upon binding with DNA or
RNA. The fragments of DNA were separated under constant voltage of 120 V for approx-
imately 30 minutes. Visualization and image acquisition was performed with the help of
Del-Doc, a UV Transilluminator by BioRAD.
7.2.8. DNA sequencing
All the constructs made during this study were sequenced at MWG Eurofins GmBh Ger-
many. The samples were prepared according to the instructions provided by the company.
Sequencing results were compared with the expected sequence to check the correctness.
7.2.9. Deletion of non-essential genes of E. coli by P1
transduction
The library of single-gene knockout-mutants of E. coli K12 (Keio Collection) was obtained
from GenoBase (Baba et al. , 2006). This collection contains 3985 single-gene deletion
mutants of non-essential genes of E. coli in a common strain background, E. coli K12
BW25113. Candidates from this collection were used to transfer the deletion mutation
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to the strain commonly used in this thesis, E. coli K12 W3110. Overnight culture of the
donor (deletion mutant from Keio collection) was diluted 1:100 in 2 tubes of 5 ml of LB
medium containing 0.2% glucose and 5 mM CaCl2 (one tube acts as a control). After few
minutes of incubation at 37 °C, 100 μl of P1 starter lysate was added to one of the tubes.
Both the tubes were incubated on a rotary shaker at 37 °C to allow growth of the cells.
After 3 hours, the clear lysate from the experimental tube was filtered with ‘Stericup 0.2
micron filter’ to get rid of the living cells. Meanwhile, 1 ml of the overnight culture of the
recipient strain was spun down at maximum speed and the pellet was re-suspended in P1
buffer (10 mM MgSO4, 5 mM CaCl2). It was then incubated at room temperature for at
least one hour (or until the lysate of the donor was ready). Once the lysate was ready, 100
μl of lysate was mixed with the equal volume of pre-treated recipient cells and incubated
for 30 min at 37 °C. Afterwards, 1 ml of LB containing 10 mM sodium citrate was added
to the mixture and incubated further for 30 min at 37 °C. Cells were then spun down and
re-suspended in 100 μl of 1 M sodium citrate and plated on LB-agar plates containing
10 mM sodium citrate and respective antibiotic to select the recombinant cells. These
plates were incubated at 37 °C for around 20 hours. The colonies obtained on these plates
were screened for the correct recombinant by colony PCR. Correct recombinants were
re-streaked on LB-agar plates containing respective antibiotic to obtain a pure strain.
7.3. Purification of Dispersin B
The plasmid pJK618, which contained the CDS of Dispersin B was a gift from Dr. Jeffrey
Kaplan, Department of Oral Biology, New Jersey Dental School, Newark, USA (Kaplan
et al. , 2003) . The CDS of Dispersin B was amplified from pJK618 and cloned in the
vector pQE60 to generate the construct pVG22. This construct contained 10X Glycine
linker and 6X histidine tag at the C-terminus of Dispersin B.
An overnight culture of E. coli M15 harboring the construct pVG22 was diluted 1:100 in
one liter of LB medium and grown at 37 °C, 110 rpm until the culture had reached OD600
of approximately 0.6. The expression of the enzyme was induced by the addition of 100
μM Isopropyl β-D-1 thiogalactopyranoside (IPTG). Expression was carried on for 4 hours
under the same conditions. The grown culture was centrifuged at 6000 rpm for 20 minutes
at 4 °C. The supernatant was discarded and the pellet was stored at -20 °C for further use.
For purification of Dispersin B, NI-IDA 2000 packed columns for purification of His-Tag
proteins from Machery-Nagel was used. The protocol for purification was performed as
mentioned in the accompanying user manual. The frozen pellet was thawed on ice and
re-suspended in 24 ml of 1X LEW buffer (provided in the kit). Lysozyme (purchased from
Sigma-Aldrich) was added to the suspension, having the final concentration of 1 mg/ml.
A tablet of Roche protease inhibitor was also added to this suspension. The suspension
was incubated on ice and was gently shaken on Heidolph gel rocker for 30 min at 4 °C.
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This was followed by sonication of the cell suspension (5 pulses of 30 s each at 50%
amplitude, 1 s on and 1s off, separated by cooling on ice for 1 min). Lysed cells were
centrifuged at 10000 rpm for 25 min at 4 °C. The supernatant (cell lysate) was carefully
separated and loaded on the Ni-IDA packed column pre-equilibrated with 1X LEW buffer.
The lysate was allowed to flow through the column matrix by gravity. The column was
washed thrice with the same 1X LEW buffer. At last, the bound protein was eluted by
adding 1X elution buffer in 3 fractions. About 90% of the protein was found in the first
fraction. However, all three elution fractions were pooled together and concentrated using
Amicon centrifugal filter units (MWCO 10 kDa, purchased from Sigma-Aldrich) at 4000
rpm for 15 min at 4 °C. The resulting concentrate was sorted in 100 μl aliquots with 5%
glycerol and flash-frozen with liquid nitrogen. Frozen protein was stored at -80 °C for
future use.
All fractions of the process of purification were analyzed by SDS-PAGE (Sodium dodecyl
sulfate- Polyacrylamide Gel Electrophoresis) (LAEMMLI, 1970).
7.4. Assay to measure the activity of Dispersin B
To measure the activity of purified Dispersin B, a simple assay was performed as de-
scribed previously (Shibata & Yagi, 1996). The substrate 4-nitrophenyl N-acetyl-beta-D-
glucosaminide (NP-GlcNAc) was dissolved in phosphate buffer to make a solution of 1
mM. Ten microliters of the purified enzyme was added to 1 ml of this solution and it was
incubated at 37 °C for 15 min. The reaction was stopped by adding 5 μl of 40% NaOH.
The intensity of the color was measured by determining the optical density of the reaction
mixture at 400 nm with the help of a Tekan Infinte M1000 Pro microplate reader.
7.5. Dispersin B secretion assay
An overnight culture of E. coli M15 harboring the construct pVG21 was diluted 1:100 in
M9 minimal medium with glucose and casein hydrolysate as a carbon source. The medium
also contained 1 mM of NP-GlcNAc. The cells were pipetted in a 96-well microplate and
grown for 24 hours at 26 °C. After incubation the change in the color of the medium was
observed and the activity of the secreted enzyme was measured as described above.
7.6. Growing and analyzing E. coli biofilms
The protocol for growing and analyzing biofilms was adapted from the one published pre-
viously (O’Toole, 2011). An overnight culture of the relevant strain of E. coli was diluted
1:1000 in LB medium and dispensed as 200 μl per well in Costar 96-well microplate (Cat-
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alog number 3585, purchased from Sigma-Aldrich). The plate was sealed with Parafilm
to avoid evaporation. It was incubated at 26 °C for a time interval depending on the
experiment. At the end of the incubation, the planktonic cells in the wells were removed
by gentle pipetting. The wells were washed thrice with phosphate buffer and the plate
was left on the bench for drying. The dried plate was then stained with 1% crystal violet
for 30 min and subsequently washed with distilled water until there is no stain seen in
the wash-water. The plate was left on the bench for drying. The stained and dried plate
was then de-stained using 70% ethanol for 30 min at room temperature. The plate was
gently shaken in a gel rocker for proper dissolution of the stain. Hundred microliters of
the dissolved stain from each well was pipetted in a new plate. The intensity of the stain
was measured by determining the optical density of the solution at 590 nm with the help
of Tekan Infinite M1000 Pro microplate reader. The intensity of the stain dissolved in
ethanol correlates to the biofilm formation.
7.7. Experiment to check the effect of Dispersin B
on E. coli biofilms
The biofilms of concerned E. coli strains were grown as described above. Planktonic cells
were gently removed and purified Dispersin B diluted in phosphate buffer was added to
the pre-formed biofilm. The plate was incubated at 37 °C for one hour. At the end of
the incubation, the plate was washed; stained and de-stained to measure the intensity as
described above.
7.8. Experiment to check the effect of Dispersin B
secreting E. coli cells on the biofilm of E. coli
csrA mutant
The csrA mutant of E. coli, TRMG1655 was a gift from Dr. Tony Romeo. The biofilm
of E. coli TRMG1655 was formed in Costar 96-well microplate for 24 hours at 26 °C.
Overnight cultures of E. coli K12 W3110 harboring the constructs pVG30 and pVG29
respectively were diluted 1:1000 in LB medium containing suitable antibiotics and were
pipetted on the pre-formed biofilm after removing the planktonic cells. The expression of
Dispersin B was induced by adding IPTG at varying concentration. The plate was further
incubated at 26 °C for varying intervals of time. At the end of this incubation, the plate
was washed, stained and de-stained to quantify the biofilm formation as described above.
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7.9. Analysis of the activity of nagE promoter
The strain of E. coli K12 W3110 containing plasmid pVG18 was grown overnight in LB
along with a control strain containing empty cloning vector pUA66. The overnight culture
was diluted 1:50 in M9 minimal medium containing glycerol as a carbon source. The
culture was distributed as 1 ml per well in Greiner 24-well flat bottom microplate (catalog
number 662102). Expression from nagE promoter was induced by adding 1, 5, 10 and 50
micromolars of N-acetyl glucosamine (purchased from Sigma-Aldrich). This culture was
grown inside Tekan Infinite 1000 Pro microplate reader at 37 °C and 168 rpm (double
orbital shake) for 3 hours. The growth of the cells (OD600) and fluorescence (excitation
488 nm, emission 510 nm) were monitored at an interval of 15 minutes. In another
experiment to assess the same activity, the culture in the same plate was grown at 37
°C, 110 rpm for 3 hours in an incubator-shaker. The culture from each well was diluted
in 1:100 in phosphate buffer. The fluorescent intensity of the cells was measured by BD
FacsCanto II flow cytometer.
7.10. Preparation of the biofilm supernatant
The overnight culture of E. coli TRMG1655 was diluted 1:1000 in 20 ml of LB medium
and poured into a sterile plastic Petri dish (Sarstedt 92x16 mm with cams, catalog number
82.1473.001). It was then sealed with parafilm and incubated at 26°C without shaking
for 24 hours. At the end of the incubation time, planktonic cells were gently removed;
attached cells were scratched with a sterile spreader and re-suspended in 1 ml of phosphate
buffer. It was then treated with purified Dispersin B (~500 μg/ml) by shaking at 37 °C,
110 rpm in an incubator-shaker for one hour. The suspension was then passed through
a syringe filter (Sartorius, Minisart SRP25, pore size 0.45 μm) to get rid off all the cells.
This filtered supernatant was then used for estimation of NAG and testing the activity of
nagE promoter.
7.11. Preparation of the Staphylococcus
epidermidis biofilm supernatant
The experiments with S. epidermidis were performed in the laboratory of Dr. Jochen
Wiesner, LOEWE center for Insect Biotechnology and Bioresources, Fraunhofer-institute
für Molekularbiologie und Angewandte Oekologie, Giessen, Germany. An overnight culture
of S. epidermidis RP62A (ATCC 35984) was grown in Tryptic Soy broth (TSB). The
overnight culture was diluted 1:1000 in TSB and dispensed in 10 Petri plates, 20 ml each.
The Petri plates were sealed with Parafilm and incubated at 37 °C for 24 hours. After the
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incubation period, planktonic cells were discarded, 2 ml of PNAG buffer was added to each
plate and the attached cells were scratched off with the help of a spreader. Scratched cells
from all the plates were pooled together and the suspension was vortexed thouroughly to
separate the clumps. The same suspension was sonicated in the sonication water bath (10
cycles of 1 min each, maximum output). It was then centrifuged at 4000 rpm for 10 min.
The supernatant was passed through a syringe filter (Sartorius, Minisart SRP25, pore size
0.45 μm) to get rid off all the cells. The filtrate was frozen in liquid nitrogen and brought
to Marburg on dry ice. This filtrate was treated as the biofilm supernatant analogous to
that of E. coli.
7.12. MBTH assay for estimating NAG
The estimation of NAG in the biofilm supernatant (prepared as above) was performed by
MBTH assay (Smith & Gilkerson, 1979). The assay was performed in small glass tubes
with metal caps. The total volume of the sample was made to 200 μl, having 0.5 M
HCl as a final concentration. The sample was heated in a water bath at 110 °C for 2
hours. After cooling to room temperature in a fume hood, 400 μl of 2.5% NaNO2 was
added. The sample was mixed well by vortexing and incubated at room temperature for 5
min. This was followed by addition of 200 μl of 12.5% ammonium sulfamate. The sample
was again vortexed and incubated at room temperature for 5 min. After this, 200 μl of
0.25% 3-methyl-2-benzothiazolone hydrazone hydrochloride (MBTH reagent, purchased
from Sigma-Aldrich) was added. The sample was incubated at 37 °C for 30 min. Two
hundred microliters of 0.5% FeCl3 was added to the sample and it was incubated again
at 37 °C for 5 min. Finally, the reaction mixture was pipetted in a 96-well microplate
(Costar catalog number 3770) and its absorbance at 650 nm was measured in Tekan
Infinite M1000 Pro microplate reader. The same procedure was also performed with NAG
(purchased from Sigma-Aldrich) having final concentration of 1 and 5 μM. The entire
assay was performed in duplicates.
7.13. Analyzing the response of nagE promoter to
the biofilm supernatant
The culture of E. coli W3110 cells harboring the construct pVG18 was grown in a 24-well
microplate exactly as described above. One hundred microliters of Dispersin B-treated
biofilm supernatant was added in one of the wells. The activity of nagE promoter was
measured by flow cytometry as indicated above.
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7.14. Analyzing the activity of nagE promoter in
the vicinity of E. coli TRMG1655 biofilm
The overnight culture of E. coli TRMG1655 was diluted 1:1000 in LB medium and pipetted
in Costar 24-well microtiter plate (catalog number 3527), one ml in each well. The plate
was incubated at 26 °C for 24 hours without shaking to allow the formation of a biofilm. An
overnight culture of E. coli W3110 harboring the construct pVG18 was diluted 1:100 in M9
minimal medium and grown at 37 °C, 200 rpm for 3 hours. Five hundred microliters of this
culture were pipetted gently on top of the pre-formed biofilm of E. coli TRMG1655 after
removing the planktonic cells. Ten microliters of purified Dispersin B (final concentration
60 µg/ml) were added to the same culture and the plate was incubated at 37 °C for one
hour. After the incubation, attached cells were scratched with the help of a pipette-tip
and re-suspended in phosphate buffer. The suspension was then used to measure the
intensity of fluorescence by flow cytometry.
7.15. Testing the activity of agr quorum-sensing
system in E. coli
E. coli W3110 harboring the constructs pVG47.1 and pVG48.2 was grown overnight in LB
medium supplemented with suitable antibiotics. The overnight culture was diluted 1:1000
in M9 minimal medium and grown in the presence of 10 μM IPTG and 10 μg/ml of AIP
(autoinducing peptide). The AIP was synthesized by EMC microcollections, Tuebingen,
Germany according the protocol published previously (Otto et al. , 1998). After growing
the cells for 3 hours at 37 °C and 200 rpm, the activity of agr system was quantified by
flow cytometry.
7.16. Testing chemotaxis on a soft agar plate
Soft agar plates were prepared by pouring minimal medium A containing 0.225% agar
in standard Petri plates. After the agar was solidified, the compound to be tested for
chemotaxis (10 μl) was spotted at the center of the plate. It was allowed to diffuse in
the agar by incubating the plate at 4 °C for 12 to 16 hours. An overnight culture of a
bacterial strain to be tested was grown in Tryptone broth (TB) and spotted at a distance
of 2 cm from the spot of the compound. Plates were further incubated at 30 °C for 24
hours. After sufficient incubation, plates were photographed for the record.
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Figure 7.1. – Setup of stimulus-dependent FRET (Dr. Karin Groesse, PhD thesis, 2013)
7.17. Stimulus dependent FRET
Stimulus dependent FRET measurement of the activity of chemotaxis pathway was done
with by using CheY-YFP and CheZ-CFP reporter pair as described previously (Sourjik et al.
, 2007; Kentner & Sourjik, 2009). Figure 7.1 describes the setup of the technique. The
same setup was used to quantify chemotaxis of E. coli towards N-acetyl glucosamine. An
overnight culture of the bacterial strain to be tested was diluted 1:100 in fresh TB medium
containing suitable antibiotics and 50 μM of IPTG and grown to OD600 of approximately
0.6 at 34 °C and 200 rpm. Cells were then spun down and re-suspended in tethering buffer
and incubated at 4 °C for at least 30 minutes. One milliliter of cells were spun down at
high speed, re-suspended in 100 μl of tethering buffer and used for FRET measurement.
Polylysine-coated coverslips were prepared by adding 20 μl of polylysine and incubating for
20 min, followed by washing with distilled water. Cells prepared for FRET measurement
were added on the coverslip, allowed to attach to polylysine and put into the flow chamber
of the flow cell. The flow chamber was maintained at a constant flow rate of 300 μl/min
with the help of a syringe pump (Harvard apparatus 22). The flow was stopped briefly to
add and remove the attractants. The flow-cell was mounted on an inverted microscope
(Zeiss Axiovert 200) and cells were focused under 40X magnification. The fluorescence
intensities of YFP and CFP were measured and FRET was calculated from the changes
in their ratio as described previously.
Dose-response measurement was performed by stimulating buffer-adapted cells with the
addition and the removal of the attractant in increasing concentration. Dynamic range
measurement was performed by stimulating attractant-adapted cells with increasing con-
centration of the attractant. In both the measurements, response to 100 μM of methyl
aspartate was used as a control.
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7.18. Growing biofilms for RNA isolation
E. coli W3110 WT and its fliC deletion mutant were used for studying biofilm transcrip-
tomics. Biofilm was grown in by diluting overnight culture 1:1000 in 20 ml of LB and
incubating it for 24 h without shaking at 26 °C in a standard Petri plate. After incubation,
planktonic cells were taken out by decanting the medium slowly. Cells attached to the
surface of the Petri plate were scratched with the help of a spreader and re-suspended in
phosphate buffer. For ΔfliC strain, only planktonic cells were harvested assuming there
are negligible attached cells. Both planktonic and attached cells were spun down and
pellet was stored at – 20 °C.
7.18.1. RNA isolation
Stored pellets of bacterial cells were thawed on ice and re-suspended in TE buffer. To-
tal RNA was isolated from cells using EURX Universal RNA Isolation kit by following
manufacturer’s instructions.
7.18.2. RNA sequencing
The isolated RNA was submitted to Genomics Core Facility at EMBL Heidelberg.
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8. Strategy
The objective of this thesis is to design an engineered bacterial system that can efficiently
disrupt a bacterial biofilm. The strategy to accomplish this task involves the following
steps.
8.1. Choosing the organism to be engineered as the
‘killer ’
Escherichia coli is the most well studied bacterium. Several systems involving genetic
engineering have been successfully developed using E. coli as a chassis. Many signaling
pathways in E. coli have been characterized (chapter 4). The pathways of protein secretion
are also well studied (section 4.4). It is convenient to handle E. coli in a laboratory setting.
Thus, I chose E. coli to design the system planned in this project. Henceforth, the ‘killer ’
will refer to the strain of E. coli that is being engineered for the planned system.
8.2. Choosing the target biofilm that would be the
‘victim’
A great deal of information is known about biofilms of different bacteria, and biofilms of
E. coli are among the most commonly studied. The composition of the matrix of E. coli
biofilms is well characterized (section 2.1). Considering the ease of handling E. coli in the
laboratory, I chose E. coli as the target biofilm to demonstrate the action of the planned
system.
Alternatively, I also considered Staphylococcus epidermidis as a ‘victim’. S. epidermidis
is a nosocomial pathogen that makes notorious biofilms on indwelling medical devices. A
great deal of information is known about the composition of its biofilm matrix (section
1.3.2). Developing an engineered bacterial system against S. epidermidis biofilms may
have applications in the healthcare sector.
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8.3. Choosing a suitable ‘weapon’ to disrupt the
target biofilm
Researchers have explored several methods to combat biofilms (chapter 3). The focus of
this project is biological methods. The ‘weapon’ to be chosen must be compatible with an
engineered bacterial system. As described earlier (section 3.4), matrix-degrading enzymes
are excellent tools that can efficiently disrupt a target biofilm. Among various enzymes
known so far, Dispersin B has been shown to be effective against E. coli and S. epidermidis
biofilms. Its synthesis involves just one step, and it is non-toxic to E. coli, allowing for
easy overexpression. It can also be easily secreted into the surrounding medium by E. coli
cells by exploiting known protein secretion pathways. I chose Dispersin B as the ‘weapon’
in the system planned in this project.
8.4. Choosing a suitable signaling pathway
The most important aspect of this project is to choose the right signaling pathway. The
signaling pathway must be able to detect the presence of the ‘victim’ and drive the synthesis
of the ‘weapon’ in response to it. I have proposed three different strategies to accomplish
this goal.
48
8.4 8
8.4.1. Using the N-acetyl glucosamine metabolic pathway
Biofilms of E. coli contain PGA (poly N-acetyl glucosamine) as one of the components
of the matrix. Dispersin B degrades PGA into its constituent monomers, N-acetyl glu-
cosamine (NAG). NAG is a small molecule that can easily diffuse in the surrounding
medium. It is a metabolite as well as a chemoattractant. E. coli possesses robust sig-
naling and metabolic pathways through which, it detects NAG present in the surrounding
medium, imports it, and metabolizes it. Thus, NAG is a highly suitable signaling molecule,
and the pathway associated with its metabolism is a fitting signaling pathway for this
project. The proposed system is described in figure 8.1. The ‘victim’ biofilm possesses
PGA and is likely to possess some free NAG as a result of the spontaneous degradation of
PGA. The ‘killer ’ detects NAG and expresses Dispersin B in response to it. Dispersin B,
secreted from the ‘killer ’ degrades PGA present in the ‘victim’ biofilm and disrupts it. The
action of Dispersin B releases more NAG, which acts as an inducer for further synthesis
of Dispersin B. The synthesis of Dispersin B continues as long as there is sufficient supply
of NAG.
Figure 8.1. – Design of the proposed system that exploits NAG metabolic pathway
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8.4.2. Using biofilm-specific gene expression
The pattern of gene expression within a biofilm can be used as a sensor, in which develop-
ment of biofilm is a response to the biofilm mode of lifestyle. The coordinated expression
of certain genes occurring in biofilms is indeed an attractive concept, which can be ex-
ploited in the planned system. In this system, the ‘killer ’ possesses a construct, in which
Dispersin B is expressed from a promoter associated with a biofilm-specific gene. As the
‘killer ’ approaches the ‘victim’ biofilm, it acquires the biofilm-lifestyle and gets incorpo-
rated into the ‘victim’ biofilm. The ’killer’ then begins to produce and secrete Dispersin
B from the biofilm-specific promoter. Dispersin B, secreted from the ‘killer ’ degrades
PGA in the ‘victim’ biofilm and disrupts the biofilm from within. Figure 8.2 describes this
concept.
Figure 8.2. – Design of the proposed system exploiting the biofilm-specific gene expression
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8.4.3. Using agr quorum-sensing system of S. epidermidis
S. epidermidis possesses a quorum-sensing system, termed agr (accessory gene regulator),
that regulates the expression of RNAII and RNAIII operons through a signaling molecule
called AIP (auto-inducing peptide). I plan to exploit this signaling system to disrupt S.
epidermidis biofilms. In this particular strategy the ‘victim’ biofilm is that of S. epidermidis
and the ‘killer ’ is the engineered E. coli. In this system, the ‘killer ’ possesses a construct, in
which Dispersin B is expressed from an RNAIII promoter. It also expresses AgrC and AgrA
proteins of S. epidermidis. The ‘victim’ biofilm makes AIP as a signaling molecule. AgrC
expressed in the ‘killer ’ detects the AIP and phosphorylates AgrA, which then activates
the synthesis of Dispersin B. Dispersin B secreted by the ‘killer ’ eventually disrupts the
‘victim’ biofilm. Figure 8.3 describes this concept.
Figure 8.3. – Design of the proposed system exploiting the quorum-sensing system of S. epidermidis
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9. Dispersin B efficiently disrupts
E. coli biofilms
Among various anti-biofilm agents explored so far, matrix-degrading enzymes are the most
attractive choice. Dispersin B is one of the well-studied matrix-degrading enzymes, which
has been demonstrated to be effective on E. coli biofilms. This chapter will describe the
efficient action of Dispersin B on E. coli biofilms and explain why E. coli TRMG1655 is
the best suitable strain to be regarded as a ‘victim’.
9.1. Cloning and purification of Dispersin B
In order to demonstrate the activity of Dispersin B on E. coli biofilms, it was essential to
clone, express and purify the enzyme. The plasmid pJK618, was used as a template to
amplify the CDS of Dispersin B, which was then cloned into the vector pQE60 along with
a 10X Glycine linker between the CDS and a 6X Histidine tag at the C- terminus. The
resulting plasmid was named as pVG22, which is illustrated in figure 9.1A.
To find the optimal condition for expression of Dispersin B, E. coli M15 cells containing
pVG22 were induced at different concentrations of IPTG (isopropyl β-D-1-thiogalactopyranoside).
The activity of the enzyme in the cell lysate was measured using a NP-GlcNAc assay (Shi-
bata & Yagi, 1996). This assay involves the use of a substrate 4-Nitrophenyl N-acetyl-
β-D-glucosaminide (NP-GlcNAc), which mimics the β, 1⇒6 linkage found in PGA. Upon
action of Dispersin B, 4-nitrophenoxide is released as a product, which can be quantified
by reading the absorbance of the reaction mixture at 400 nm. The activity of the enzyme
was found to be saturating after induction by 100 μM of IPTG (figure 9.1B). It was also
observed that cell growth was compromised at concentrations of IPTG higher than 100
μM. I therefore used 100 μM of IPTG for the expression and purification of Dispersin B.
Dispersin B was purified by using Ni-IDA packed columns from Machery-Nagel (figure
9.1C), and the enzyme was sufficiently enriched in the process of purification (figure
9.1D). The amount of protein in the final stage of purification was ~ 6 mg/ml.
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Figure 9.1. – Cloning and purification of Dispersin B A. Design of the construct pVG21, B. Activity
of Dispersin B in the cell lysate upon induction at various concentrations of IPTG, C.
SDS-PAGE analysis of the different steps of purification of Dispersin B, D. Activity
of Dispersin B in the different steps of its purification
9.2. The effect of Dispersin B on various strains of
E. coli
Biofilms of different strains of E. coli were grown in 96-well microtiter plates. The 24 h old
biofilms were treated with purified Dispersin B for one hour, and the effect of the treatment
was quantified by crystal violet staining. This simple method is semi-quantitative, as it
measures only cell attachment and does not consider three-dimensional biofilm structure.
As described earlier, a biofilm is not just a layer of attached cells but rather a dynamic
three-dimensional structure. Though this structure is an important element of biofilms,
in this case, the intent was only to check if the biofilm is disrupted by enzyme treatment.
Thus, the crystal violet staining method, despite being semi-quantitative, was sufficient
for studying biofilm disruption for the purpose of this project.
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9.2.1. The effect of Dispersin B on the biofilms of WT strains
of E. coli
There are various WT strains of E. coli used in the scientific community, each of which
has a different capacity for biofilm formation and a different biofilm architecture. I have
used the strains MG1655, W3110, W3110RH and W3110AR (section 2.2) to check for
the effects of Dispersin B. It was observed that there was ~ 20% reduction in biofilm
formation of E. coli MG1655 due to the treatment with Dispersin B. For other strains,
however, there was no significant effect (figure 9.2a). Biofilm formation by the same set
of strains was carried out in the presence of Dispersin B. It was found that all strains
showed 20-40% reduction in biofilm formation when grown in the presence of Dispersin B
(figure 9.2b). This observation confirmed the fact that PGA is more relevant in the initial
stage of biofilm formation than in the later stages of biofilm maturation.
Figure 9.2. – The effect of Dispersin B on various WT strains of E. coli A. Pre-formed biofilms
treated with 60 μg/ml of Dispersin B, B. Biofilms grown in the presence of 60 μg/ml
of Dispersin B
9.2.2. The effect of Dispersin B on the biofilm of E. coli
TRMG1655
The protein CsrA regulates the switch from the planktonic state to the biofilm-lifestyle. It
drives the cell towards motility and reduces its likelihood of investing in biofilm production.
The csrA mutant of E. coli (TRMG1655, shortly referred as TRMG) exhibits hightened
biofilm formation. Since the effect of Dispersin B on this strain was already documented
(Itoh et al. , 2005), I decided to compare the TRMG strain with WT strains of E. coli
used above for their susceptibility to Dispersin B. The TRMG strain formed more robust
biofilms in comparison to WT under the same set of conditions. The TRMG biofilm was
grown for 24 h as well as 48 h, and the effect of Dispersin B on it was assessed by crystal
violet staining. Dispersin B treatment disrupted most of 24 h old biofilms and induced
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a ~ 40% reduction in 48 h old biofilm biomass (figure 9.3). Almost 100% removal of
24 h old TRMG biofilm was dramatic in comparison to 20% removal of its isogenic WT.
This experiment confirmed that TRMG was the best suitable strain to be considered as a
‘victim’.
Figure 9.3. – The effect of Dispersin B (60 μg/ml) on the 24 h old pre-formed biofilm of E. coli
TRMG1655
9.3. Secretion of Dispersin B
The proposed system requires that the anti-biofilm agent Dispersin B should be synthesized
and secreted by ‘killer ’ cells. To make E. coli cells secrete Dispersin B, it was essential to
choose the right strategy for secretion. I chose the simplest method of fusing the secretion
signal of OmpA to the enzyme. The nucleotide sequence encoding first 21 amino acids of
OmpA was fused to the CDS of Dispersin B at its 5’ end and the resultant fragment was
cloned into the vector pTrc99a. The resultant construct was named pVG30 (figure 9.4A).
The E. coli cells harboring pVG30 were induced with various concentrations of IPTG and
grown in the medium containing NP-GlcNAc. After an overnight growth, presence of the
enzyme in the medium was confirmed measuring the OD of the spent medium at 400
nm. It was observed that fusing the secretion signal of OmpA to Dispersin B successfully
drove it out of the cell (figure 9.4B). The maximum amount of enzyme was found to be
secreted when the cells were induced at 100 μM of IPTG.
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Figure 9.4. – The ’killer’ cell secretes Dispersin B A. The design of the constructs pVG29 and
pVG30, B. Secretion of Dispersin B from the cells harboring different constructs
induced with different concentrations of IPTG
9.4. The ‘Killer’ secreting Dispersin B disrupts the
‘victim’ biofilm
To demonstrate the effect of the secreted enzyme on the ‘victim’ biofilm, a pre-formed
biofilm of TRMG was treated with E. coli W3110 cells harboring pVG30. The expression
of OmpA::DspB was induced by adding 100 μM of IPTG. The effect of this treatment
was quantified by crystal violet staining as described previously. The TRMG biofilm was
reduced by 87% due to Dispersin B secreted by the ‘killer ’ (figure 9.5a). Different com-
binations of the inducer concentration and treatment time were attempted in order to
determine the most suitable condition for this treatment. It was evident that a minimum
of 12 h of treatment was necessary to observe an approximately 50% reduction in the
TRMG biofilm (figure 9.5b). In conclusion, Dispersin B secreted by the ‘killer ’ cells was
able to successfully disrupt the ‘victim’ biofilm.
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Figure 9.5. – The ’killer’ secreting Dispersin B disrupts the biofilm of E. coli TRMG1655 A. The 24
h old pre-formed biofilm of E. coli TRMG1655 treated with E. coli W3110 harboring
various constructs, B. The disruption of the pre-formed biofilm of E. coli TRMG1655
by Dispersin B secreted by E. coli W3110 harboring the construct pVG30, induced at
different concentrations of IPTG for variable time
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10. Characterization of the NAG
signaling pathway of E. coli
After demonstrating the successful action of the ‘killer ’ on the ‘victim’ biofilm, the next
step was to combine the expression of Dispersin B with a biofilm-specific signaling pathway.
The first strategy is to exploit the NAG signaling pathway of E. coli. The ‘victim’ biofilm
is rich in PGA, a polymer of NAG. In the proposed system, NAG generated from the
action of Dispersin B acts as an inducer for activating the expression of Dispersin B. This
will generate a system in which, synthesis of Dispersin B continues as long as there is a
supply of NAG from the ‘victim’ biofilm (figure 8.1). This chapter describes how the NAG
signaling pathway was characterized and how it could be combined with the expression of
Dispersin B.
10.1. Analysis of the activity of the nagE promoter
The first and foremost task in this strategy was to analyze how the signaling and metabolic
pathway of NAG responds to extracellular NAG. E. coli harbors the nagE/BACD operon
that contains genes encoding enzymes involved in the metabolism of NAG. The organi-
zation of the operon and functions of its constituent genes are well known (Plumbridge,
1991). The intergenic region between nagE and nagB was cloned into the cloning vector
pUA66. This cloning vector contains the CDS of gfpmut3 and a set of restriction enzyme
sites upstream (Zaslaver et al. , 2006). Any putative promoter could be cloned in these
sites and its activity studied by measuring GFP expression. The resultant construct was
named pVG18 (figure 10.1A). In this construct, the promoter of nagE drives the expression
of GFP upon induction by NAG.
E. coli W3110 WT cells harboring the construct pVG18 were grown in M9 minimal medium
supplemented with varying concentrations of NAG for a few hours, and the level of GFP
expressed in them was measured by flow cytometry. Average GFP fluorescence per cell was
considered as a proxy for the activity of the nagE promoter. Figure 10.1B illustrates GFP
fluorescence per cell after three hours of growth in the presence of NAG. The minimum
concentration required to activate the nagE promoter by two fold was 50 μM.
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Figure 10.1. – Analysis of the activity of the nagE promoter A. Design of the construct pVG18, B.
Activity of the nagE promoter at various concentrations of NAG measured by flow
cytometry, C. Activity of the nagE promoter at various intervals of time, D. Change
in the activity of the nagE promoter per unit time
Since cells utilize NAG as a carbon source, the effective concentration of NAG in the
medium might have decreased over time. Thus, I decided to measure the expression
of GFP at certain intervals of time after induction (figure 10.1C). The change in the
expression of GFP per unit time was calculated and normalized to the cell density (figure
10.1D). It was observed that at 5 and 10 μM of NAG, the activity of the nagE promoter
started declining immediately as cells began to grow and divide. At 50 and 100 μM of
NAG nagE promoter activity increased for 50 and 80 minutes respectively and declined
thereafter. This implied that E. coli cells could rapidly utilize small amounts of NAG.
The synthesized GFP remained stable inside the cells for the time interval within which
the cells were observed. The nagE promoter thus responded well to extracellular NAG,
however it was not sensitive to low concentrations of NAG.
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10.2. Estimating the concentration of NAG in
TRMG biofilms
After determining the NAG concentration range within which the nagE promoter responds,
it was necessary to estimate the concentration of NAG in the TRMG biofilm that is
treated with Dispersin B. Biofilms of E. coli TRMG contain PGA as the most important
constituent. As PGA is a polymer of NAG, it could be expected that TRMG biofilms
liberate some NAG due to spontaneous PGA degradation. Treatment with Dispersin B
would presumably generate more NAG due to its action on the polymer. Thus, I decided
to estimate NAG present in the Dispersin B-treated and untreated biofilm supernatant
of TRMG biofilm. I performed MBTH assay (Smith & Gilkerson, 1979) to estimate
the concentration of NAG in TRMG biofilm. The reagent 3-methyl-2-benzothiazolone
hydrazone (MBTH) reacts with aldehydes in the presence of Fe3+ ions to give rise to a
strongly colored complex whose concentration can be measured as the optical density at
650 nm.
TRMG biofilms were grown in 10 ml cultures and supernatants were prepared by scratching
the attached cells off the surface (section 7.10). Scratching merely detaches the cells
from the surface and does not affect the biochemical nature of matrix components. The
supernatant was treated with Dispersin B for one hour and then used for estimation of
NAG content. The supernatant of TRMG biofilm contained less than 1 μM of NAG
(figure 10.2A). There was a small difference observed between Dispersin B treated and
untreated supernatant. These results indicated that there was detectable NAG in the
biofilm supernatant. Since PGA is strongly attached to the cell surface (Wang et al. ,
2004), the procedure of biofilm supernatant preparation might not have isolated entirety
of PGA in biofilms. Considering these points, the measurement of NAG in TRMG biofilms
could be an underestimate. Regardless of how much NAG was present in TRMG biofilm;
it was interesting to see if the nagE promoter responded to it.
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Figure 10.2. – A. Estimation of NAG in the biofilm supernatant of TRMG by MBTH assay, B.
Response of the nagE promoter to the biofilm supernatant of TRMG
10.3. Response of the nagE promoter to NAG
released from the ‘victim’ biofilm
Since the nagE promoter responded well to the extracellular NAG, it was interesting
to check if it could also respond to NAG present in TRMG biofilms. I used the same
biofilm supernatant that was subjected to MBTH assay above to check for its effect on
the activity of the nagE promoter. The cells were grown in the presence of the biofilm
supernatant and the activity of the nagE promoter was measured by flow cytometry. It was
observed that the biofilm supernatant, whether treated with Dispersin B or untreated was
unable to activate the nagE promoter above its basal level of expression (figure 10.2B).
The procedure of biofilm supernatant preparation was the same as that used above for
chemical estimation of NAG. It was already stated that this procedure might not have
isolated all of PGA found in the biofilm. As a result, this procedure might have diluted
NAG to such an extent that its final concentration was too low to induce any change in
the activity of the nagE promoter.
To circumvent the issue of dilution, it was decided to directly add cells containing pVG18
(nagE reporter cells) on the pre-formed TRMG biofilm and test the activity of the nagE
promoter following the treatment with Dispersin B. When the reporter cells stay in close
contact with the TRMG biofilm, NAG released from the TRMG biofilm surrounds them.
In that case, reporter cells would be directly exposed to the actual concentration of NAG in
the TRMG biofilm and respond to it. In order to test this hypothesis, a pre-formed TRMG
biofilm was treated with Dispersin B and reporter cells were added to it. The treatment
was performed for one hour. The treated biofilm was scratched and tested for the activity
of the nagE promoter by flow cytometry. The outcome of the experiment is shown in
figure 10.3. The basal expression from the nagE promoter was much less than that in the
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above experiment. It was difficult to distinguish between the populations of the ‘killer ’
and the ‘victim’. It was evident from the scatter plots that the treatment with Dispersin
B indeed disrupted the large clumps of cells in the TRMG biofilm. Individual cells of the
TRMG biofilm formed as a result of this disruption overlapped with the reporter cells.
This complicated the interpretation of the effect of Dispersin B treatment on the activity
of nagE promoter. However, no obvious increase in the activity of the nagE promoter was
observed.
Figure 10.3. – The activity of the nagE promoter when the reporter cells were incubated with the
Dispersin B-treated TRMG biofilm
10.4. Overexpressing the pgaABCD operon in
TRMG biofilm
Considering the observations from the previous experiments it was clear that the TRMG
biofilm does not make enough PGA so that its degradation generates NAG that will activate
the nagE promoter. However, the concept of synthesizing Dispersin B from the nagE
promoter might still work if the biofilm makes more PGA. In order to test this hypothesis,
entire pgaABCD operon was cloned and expressed in the TRMG strain. Biofilm formation
62
10.5 10
under different levels of overexpression of pgaABCD operon was studied by crystal violet
staining. Overexpression of the pgaABCD operon at low levels of induction reduced
biofilm formation.The highest level of overexpression of the pgaABCD operon resulted in
less than a 2.5 fold increase in biofilm formation with respect to the TRMG strain (figure
10.4A). Since there are many other factors involved in biofilm formation, higher synthesis
of PGA might not result in higher biofilm formation. However, the biofilm may contain
the polymer of PGA in excess amount. Thus, I prepared the supernatant from the TRMG
biofilm overexpressing the pgaABCD operon at the highest possible level and tested it for
the activation of the nagE promoter. Unfortunately, the nagE promoter did not show any
increase in its activity above the basal level in the presence of the biofilm supernatant
(figure 10.4B). This observation indirectly suggested that overexpressing genes involved
in PGA synthesis resulted in higher synthesis of the polymer, however its degradation into
NAG was not sufficient to induce the nagE promoter.
Figure 10.4. – Overexpressing the pgaABCD operon in the TRMG biofilm A. Biofilm formation
at various levels of induction of the pgaABCD operon, B. Activity of the nagE
promoter when reporter cells were incubated with the Dispersin B-treated TRMG
biofilm overexpressing the pgaABCD operon
10.5. Response of the nagE promoter to the biofilm
supernatant of S. epidermidis
The biofilm of S. epidermidis contains PIA (polysaccharide intercellular adhesin) as a
major component. This polysaccharide is essentially the same as the PGA polymer found
in E. coli. It was also shown that Dispersin B successfully disrupts S. epidermidis biofilms
(Kaplan et al. , 2004). Thus, I decided to test the activity of the nagE promoter in
the presence of Dispersin B-treated biofilm supernatant of S. epidermidis. The biofilm
supernatant was prepared in the same way as that of E. coli and was treated with Dispersin
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B for one hour. E. coli cells harboring the construct pVG18 were grown in the presence
of the biofilm supernatant and the activity of the nagE promoter was measured by flow
cytometry. Unfortunately, there was no significant increase observed in the activity of
nagE promoter in the presence of the biofilm supernatant (data not shown).
10.6. Improving the sensitivity of the nagE
promoter
The observations above made it clear that the TRMG biofilm did not make enough PGA
to generate NAG that could activate the nagE promoter under the culture and assay
conditions used here. However, it could be possible to alter the components of the
nagBACD operon and improve the sensitivity of the nagE promoter so that it responds
to the concentration of NAG lower than its normal level of activation. Here, sensitivity
refers to the fold-change in the activity of the nagE promoter at concentrations of NAG
between 1 to 10 μM.
Since NAG is a metabolite, there is always some amount of NAG present inside the E. coli
cell. This NAG is in the form of NAG-6-phosphate, which is able to bind to NagC and
de-repress the expression of nagE and nagBACD. This basal level of NAG-6-P contributes
to the activity of the nagE promoter without any induction from NAG present in the
surrounding medium. In short, the nagE promoter has a high level of leaky expression due
to the presence of intracellular NAG-6-P. If this intracellular NAG-6-P could be reduced,
it would result in low basal activity of the nagE promoter and consequently, higher fold-
change in its activity around 1 μM of NAG.
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10.6.1. Overexpression of NagC
One way to improve the sensitivity of the nagE promoter could be overexpression of
NagC. High levels of NagC would saturate the existing NAG-6-P and the repressor would
be free to respond to NAG being taken up from the environment. To test this hypothesis,
the nagC gene was cloned and co-expressed along with pVG18 in E. coli W3110 cells.
The cells were grown in the presence of NAG and the activity of the nagE promoter
was estimated by flow cytometry. Figure 10.5A shows the activity of the nagE promoter
at different concentrations of NAG when NagC was overexpressed by adding 100 μM
of IPTG. It is clear that the overexpression of NagC reduced the activity of the nagE
promoter at different concentrations of NAG. The fold-change in nagE promoter activity
at a particular concentration of NAG decreased slightly until 10 μM of NAG and increased
thereafter. However, the fold-change was always less than unity, indicating reduction in
nagE promoter activity at all concentrations of NAG. Figure 10.5B shows the activity of
the nagE promoter normalized to its basal expression. It reflects the same trend as that
of figure A. The fold-change in the activity of the nagE promoter at concentrations of
NAG between 1 to 10 μM remained unaffected in the presence of overexpressed NagC.
The overexpression of the repressor therefore did not result in the intended improvement
in the sensitivity of the nagE promoter.
Figure 10.5. – Effect of the overexpression of NagC on the activity of the nagE promoter A. Activity
of the nagE promoter at various concentrations of NAG in the presence of NagC
and the fold-change in the activity at respective concentrations of NAG, B. Activity
of the nagE promoter normalized to its basal activity at various concentrations of
NAG in the presence of overexpressed NagC
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10.6.2. Overexpression of NagB and NagA
Another way to reduce the basal activity of the nagE promoter would be to overexpress
the enzymes involved in the catabolism of NAG. High levels of NagB and NagA would
catabolize the existing NAG-6-P and keep the repressor bound to the operator region of
the nagE promoter. This would eventually reduce the basal activity of nagE promoter. To
test this hypothesis, nagB and nagA genes were cloned in a single bicistronic construct and
co-expressed along with pVG18, and the activity of the nagE promoter was measured in the
same manner as above. Figure 10.6A shows the activity of the nagE promoter at different
concentrations of NAG. The fold-change in the activity at a particular concentration of
NAG descreased continuously with the increasing concentration of NAG. However, like
the overexpression of NagC the fold-change was always less than unity, implying the
reduction in nagE promoter activity. Figure 10.6B shows the activity of the nagE promoter
normalized to its basal expression. The fold-change at concentrations of NAG between 1
to 10 μM was lowered in the presence of overexpressed NagB and NagA. In conclusion,
this modification also could not result in improving the sensitivity of the nagE promoter.
Figure 10.6. – Effect of the overexpression of NagB and NagA on the activity of the nagE promoter
A. Activity of the nagE promoter at various concentrations of NAG in the presence
of overexpressed NagB and NagA and the fold-change in the activity at respective
concentrations of NAG, B. Activity of the nagE promoter normalized to its basal
activity at various concentrations of NAG in the presence of overexpressed NagB
and NagA
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10.6.3. Overexpression of NagE
The last possibility of achieving the improved sensitivity of the nagE promoter was to
overexpress NagE- the transporter of NAG. The greater the number of transporters, the
greater the amount of NAG taken up by the cell. This may enhance the ability of the cell
to take up NAG from the environment even if its concentration in the surrounding medium
is low. It would eventually lead to higher activity of the nagE promoter at low extracellular
concentration of NAG. To test this hypothesis, the nagE gene of E. coli was cloned and
co-expressed with pVG18, and the activity of the nagE promoter was measured. In this
case, the change in the activity of the nagE promoter was monitored every 15 minutes
while growing the cells simultaneously inside the Tekan microplate reader. There was
no change observed in the activity of the nagE promoter due to the overexpression of
nagE (data not shown). The last possibility of achieving improved sensitivity of the nagE
promoter did not materialize.
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11. Chemotaxis towards NAG
Chemotaxis is the migration of an organism towards a chemical stimulus. Chemotaxis in E.
coli is a well-studied signaling pathway. Being relatively simple and robust, it is amenable
to manipulation. In the proposed system, exploiting the chemotactic signaling pathway
that induces migration towards NAG could enhance efficiency of the system. The ‘killer ’
would not only move towards the ‘victim’ biofilm, but also make Dispersin B in the close
vicinity of the ‘victim’. Thus, combining Dispersin B expression with chemotaxis was an
attractive strategy. This chapter will describe the characterization of chemotaxis towards
NAG and attempts made to improve the chemotactic response of the cells in order to be
suitable for the proposed system.
For E. coli, NAG is a strong chemoattractant. The first reference to NAG as a chemoat-
tractant for E. coli dates to the preliminary work on bacterial chemotaxis by James Adler
(Adler, 1976). In this work, chemotaxis of E. coli towards NAG was demonstrated by a
capillary assay. The methods of analyzing bacterial chemotaxis have evolved over time,
and many more compounds are now characterized as chemoattractants. However, there
are no further references in the literature concerning chemotaxis towards NAG. Thus, I
thought of first characterizing chemotaxis towards NAG with the help of methods available
in the lab.
11.1. Analyzing chemotaxis towards NAG by
stimulus dependent flow-FRET
With the help of advanced biophysical techniques, it is now possible to quantitatively
analyze the signal processing of the chemotactic pathway of E. coli (Sourjik et al. , 2007).
I used the flow-FRET (fluorescence resonance energy transfer) setup in the lab to analyze
chemotaxis of E. coli towards NAG. Figure 11.1 describes the concept underlying this
technique. The proteins CheY and CheZ are fused with YFP and CFP, respectively. When
these two proteins interact, FRET takes place and there is a drop in the fluorescence of CFP
and gain in that of YFP. In the absence of an attractant CheY and CheZ bind and dissociate
as a steady state. Thus, the ratio of YFP and CFP fluorescence remains constant. When
an attractant binds to the receptor, the kinase activity of CheA is inhibited, resulting in
a sudden drop of CheY-P. Subsequently, CheY and CheZ dissociate, which is followed by
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a gain in the fluorescence of CFP and drop in that of YFP. The change in the kinase
activity of CheA can be quantified by monitoring the ratio of YFP and CFP fluorescence.
A drop in this ratio indicates the presence of an attractant and a gain in the ratio indicates
removal of an attractant.
Figure 11.1. – The concept of stimulus-dependent flow-FRET A. Interaction of CheY-YFP and
CheZ-CFP in the presence or absence of the attractant, B. Change in the kinase
activity in the presence or absence of the attractant
To analyze the chemotactic response of E. coli towards NAG, buffer-adapted cells were
stimulated with various concentration of NAG and the kinase activity of CheA in response
to the stimulus was measured. It was found that NAG was able to inhibit the kinase
activity in the range of 1 to 10 μM (figure 11.2).
Figure 11.2. – Chemotaxis of E. coli LJ110 towards NAG analyzed by stimulus-dependent flow-
FRET
As evident from the above experiments, biofilm of TRMG contains not more than 10 μM
of NAG. The concentration of NAG, which is already low in the biofilm, is likely to drop
several fold when it diffuses away from the biofilm. For chemotaxis towards NAG to be
helpful for the proposed system, the ‘killer ’ must be able to respond to NAG at some
distance away from the biofilm. Thus, the system would work only if the ‘killer ’ shows
chemotaxis towards NAG at concentrations within nanomolar range. In order to design a
strategy for improving chemotactic response towards NAG, it was important to understand
the exact mechanism of chemotaxis towards NAG.
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11.2. Chemotaxis towards NAG is PTS-mediated
and not receptor-mediated
As described earlier, E. coli shows chemotaxis to various compounds via either receptor
(MCP) mediated pathway or PTS-mediated pathway. Generally, chemotaxis towards sug-
ars occurs via PTS-mediated pathway. Since NAG is a sugar, chemotactic response to
it was more likely to occur via PTS, however, the possibility of chemotaxis through a
receptor like Trg could not be ruled out. Thus, I decided to examine the chemotaxis of E.
coli towards NAG by swarm plate assay (Wolfe & Berg, 1989). In this assay, an attractant
is spotted in the center of a Petri plate containing M9 minimal medium with 0.225 %
agar. In soft agar, cells can swim through the pores created by the polysaccharide network.
As they spread from the point of inoculation, they consume nutrients and thus create a
nutrient gradient. This results in the formation of a ring with distinct alternating regions
of cell density. When cells move more towards an attractant, they make an egg-shaped
ring pointing towards the increasing gradient of the attractant.
In this experiment, the goal is to unravel the exact pathway of chemotaxis towards NAG.
Thus, chemotaxis of the WT E. coli LJ110 was tested along with some suitable mutants.
The first and foremost mutant that was constructed was nagE deletion mutant (ΔnagE ).
The second mutant was a double deletion mutant of ptsI and cpdA (ΔptsIΔcpdA). This
deletion abolishes all the phosphotransferase systems in the cell. The third mutant used
was a strain of E. coli, in which all five MCPs are deleted (UU1250). It has no functional
cluster of MCP-CheA-CheW and it does not show any chemotactic response towards any
compound. The attractant, which is 100 mM of NAG was spotted at the center of the soft-
agar plate and allowed to diffuse in the agar overnight. Overnight cultures of the above
mentioned mutants were spotted at positions equidistant from the center. The plate was
incubated to allow the formation of the swarm rings. Figure 11.3 shows the results of the
experiment. The WT of E. coli showed a conspicuous egg-shaped swarm ring pointing
towards the increasing concentration of NAG. The ΔnagE strain formed a much smaller
swarm ring in comparison to the WT strain. This could be due to slower growth rate
of ΔnagE strain on minimal medium. It showed chemotaxis towards methyl aspartate,
which implied that it was not impaired in the chemotactic signaling pathway. It did not
show any chemotaxis towards NAG. The strain UU1250 showed no chemotaxis towards
methyl aspartate or NAG. Its phenotype on the plate was an example of complete lack of
chemotaxis (negative control). The ΔptsIΔcpdA strain showed a chemotactic response
towards methyl aspartate, implying its functional chemotactic signaling pathway. However,
it showed no chemotaxis towards NAG, which conveyed that PtsI plays an essential role
in chemotaxis towards NAG.
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Figure 11.3. – Swarm plate assay for chemotaxis A. towards 100 mM NAG, B. towards 100 mM
methyl aspartate
Although the swarm plate assay implied that chemotaxis towards NAG is PTS-mediated,
it was not reliable due to different growth rates of mutants on the minimal medium.
Thus, I decided to test these mutants by stimulus dependent flow-FRET for chemotaxis
towards NAG. The deletion mutant of nagE showed the same response to NAG as that
of the WT strain. Surprisingly, deleting the transporter of NAG had no effect on the
concentration range within which the cells showed inhibition of kinase activity (figure
11.4A). The amplitude of the drop in the ratio of YFP and CFP signal also remained
the same, as that of the WT strain. In short, other transporters like ManXYZ, which
also transport NAG inside the cell, were able to compensate for the lack of NagE. The
double knockout of ptsI and cpdA showed no response to NAG (figure 11.4B). It showed
a minute response to glucose, to which chemotaxis is mostly PTS-mediated, but is also
known to take place through the receptor Trg. The mutant responded to methyl aspartate
in the same manner as that of the WT strain. Chemotaxis to methyl aspartate is entirely
receptor-mediated, indicating the presence of a functional chemotactic signaling pathway
in the mutant. From these observations, it was concluded that chemotaxis towards NAG
occurs entirely through PTS and not through any chemoreceptor.
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Figure 11.4. – Chemotaxis of the deletion mutants of E. coli LJ110 towards NAG analyzed by
stimulus dependent flow-FRET A. ΔnagE (order of the stimuli 1- 100 μM MeAsp,
2- 100 nM NAG, 3- 1 μM NAG, 4- 3 μM NAG, 5- 10 μM NAG, 6- 30 μM NAG. 7-
100 μM NAG, 8- 300 μM NAG, 9- 1 mM NAG, 10- 3 mM NAG), B. ΔptsIΔcpdA
(order of the stimuli 1- 100 μM MeAsp, 2- 100 μM Glucose, 3- 10 μM NAG)
11.3. Improving chemotaxis towards NAG
Since the chemotactic response of the WT E. coli to NAG was not suitable for the pro-
posed system, I considered whether the chemotactic response could be improved. Here,
improvement in chemotaxis means enabling the cells to show stronger chemotaxis towards
NAG at concentrations lower than 1 μM. The transporter NagE is the chief player involved
in the chemotaxis towards NAG. The construct expressing NagE was co-transformed with
the construct expressing the FRET-pair in the WT E. coli. The transporter NagE was over-
expressed by adding different concentrations of the inducer and the chemotactic response
towards NAG was measured. Unfortunately, the cells overexpressing the transporter could
not respond to NAG under the setup of flow-FRET. This was perhaps due to excess stress
caused to the cell due to the overexpression of a membrane protein.
The ΔnagE strain had no effect on the chemotaxis towards NAG. Overexpressing the
transporter in theΔnagE strain may not cause too much stress to the cell. Thus, I decided
to overexpress NagE in the deletion mutant of nagE and test the cells for the chemotaxis
towards NAG. In this experiment, cells were stimulated with increasing concentrations
of NAG without adding the buffer in-between. This method helps us to elucidate the
range of the concentration of the attractant within which the cells are responsive to the
attractant in spite of adaptation mechanism performed by CheB and CheR (section 4.2.2).
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Unfortunately, it was observed that overexpressing nagE had no effect on the chemotactic
response of the cells towards NAG (figure 11.5).
Figure 11.5. – Chemotaxis towards NAG upon overexpression of NagE in the nagE deletion mutant
of E. coli LJ110 A. Cells uninduced (order of the stimuli 1- 100 μM MeAsp, 2- 100
nM NAG, 3- 1 μM NAG, 4- 3 μM NAG, 5- 10 μM NAG, 6- 30 μM, 7- 100 μM) B.
Cells induced with 0.0001% arabinose (order of the stimuli is the same as A)
Above experiments made it clear that E. coli was naturally chemotactic towards NAG.
However, the range of concentration of NAG within which it showed chemotaxis was not
sufficient in the context of the proposed system. Attempts made to improve the chemo-
tactic response of E. coli also did not succeed. In conclusion, the idea that chemotaxis
towards NAG could enhance the efficiency of the proposed system was not feasible.
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12. Exploring differential
regulation of gene expression
in biofilms
The biofilm lifestyle is fundamentally different from the planktonic lifestyle. The coordi-
nated change in the phenotype of bacterial cells during biofilm formation gave rise to the
assumption that this change is brought about by a specific pattern of gene expression.
Any single gene that is a part of this pattern is likely to get activated by several fold
during biofilm formation. That hypothetical biofilm-induced gene is particularly attractive
for the proposed system. The promoter associated with this gene can drive the expression
of Dispersin B. In this system, Dispersin B would be expressed and secreted as soon as
the ‘killer ’ approaches the ‘victim’ biofilm and acquires the biofilm lifestyle. The ‘killer ’
cells, now a part of the biofilm, would then disrupt the ‘victim’ biofilm from within.
Researchers have explored the biofilm-specific gene expression by performing DNA microarray-
based identification of genes expressed in E. coli biofilm. Some of the key findings of the
experiments performed previously have been described (1.5). The most important con-
clusion of the studies to date is variability in gene expression pattern due to differences
in the makeup of the strain, and the conditions used to grow biofilms. In order to find a
gene(s) that is up-regulated in the biofilm grown under conditions used in this project, it
was essential to sequence its transcriptome.
Genome-wide studies of bacterial gene expression are shifting from hybridization-based
technology to next generation sequencing technology. RNA-seq has a number of ad-
vantages over using DNA microarrays. It offers annotation-independent detection of tran-
scription, improved sensitivity and increased dynamic range (Croucher & Thomson, 2010).
Thus, I decided to perform RNA-seq to explore the pattern of biofilm-specific gene expres-
sion. The biofilms of E. coli W3110 were grown for 24 hours and planktonic and attached
cells were harvested. Exponentially growing cells of the same strain were also harvested.
Since the deletion mutant of fliC shows significantly less biofilm formation, it was grown
in the same conditions as that of the WT biofilms and the planktonic cells (assuming no
attachment) were harvested. All these samples were then subjected to the isolation of the
total RNA, which was submitted to the sequencing facility.
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12.1. Analyzing the data obtained from RNA-seq of
E. coli biofilms
As the first step of the analysis, the transcriptomes of the attached cells and planktonic
cells of the WT biofilms were each compared with that of the exponential phase cells of the
WT strain. It was observed that many genes that were up regulated in attached cells with
respect to the exponential phase cells were also up regulated in planktonic cells (Figure
12.1 ). Most of the genes up regulated in biofilms encode proteins involved in metabolic
processes such as glycolate metabolism, fatty acid oxidation, oxidoreductase activity, and
others. There are also some genes, which are involved in responding to extracytoplasmic
stress (cpxP), regulation of capsule synthesis (rcsB), regulation of curli assembly (csgD)
and some other regulatory functions. These observations are in agreement with the findings
of the previous work (Beloin et al. , 2004).
Figure 12.1. – Genes up regulated in planktonic cells and attached cells of the biofilm w.r.t. expo-
nential phase cells of E. coli W3110 (> 4 fold, p < 0.01)
The transcriptome of the planktonic cells of the deletion mutant of fliC was compared
with that of the other samples. It was found that the pattern of gene expression in this
mutant was similar to that of the planktonic cells of the WT. This implies that the mutant
that was unable to form biofilms, was also not showing any similarity in its pattern of gene
expression to that of the attached cells of the WT (data not shown).
In order to find the genes that were specifically up regulated in attached cells, the tran-
scriptome of the attached cells was compared with that of the exponential phase cells and
the genes that were up-regulated in planktonic cells were filtered out. The result of this
filtering is listed in table 12.1 . The interesting observation here is that most of the genes
in this list encode enzymes required for oxidative stress. In deeper layers of the biofilm,
oxygen concentration drops rapidly. Finding the enzymes involved in combating oxidative
stress in the highly anaerobic microenvironment is counter-intuitive. It is interesting to
explore into this further.
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Table 12.1. – Genes up regulated in attached cells but not in planktonic cells of the biofilm (>
2-fold, p < 0.05)
Name DB Object Name Attached
cells
(total
RPKM)
Planktonic
cells
(total
RPKM)
Exponential
phase
cells
(total
RPKM)
Fold
change
att
vs
exp
Fold
change
pla
vs
exp
grxA reduced
glutaredoxin 1
12.07 5.38 6.00 67.42 0.65
katG catalase/peroxidase
HPI
11.89 6.81 7.15 26.67 0.79
oxyS Putative hydrogen
peroxide-inducible
genes activator
7.33 1.77 2.81 22.86 0.48
hemH ferrochelatase 9.13 5.44 5.58 11.75 0.91
ahpF alkyl
hydroperoxide
reductase, F
subunit
11.26 6.41 7.72 11.58 0.40
yaaA protein that
reduces
intracellular iron
levels under
peroxide stress
9.37 5.51 5.89 11.12 0.77
sufA iron-sulfur cluster
assembly scaffold
SufA
8.71 3.41 5.73 7.90 0.20
ycaD YcaD MFS
transporter
7.14 4.01 4.24 7.44 0.85
yifE 12.12 9.11 9.38 6.70 0.83
ahpC alkyl
hydroperoxide
reductase, C
subunit
13.29 10.00 10.66 6.18 0.63
ymgG 4.39 1.66 2.11 4.86 0.73
xthA exodeoxyribonuclease
III
9.07 6.47 7.12 3.88 0.64
yfiP 7.08 4.84 5.36 3.28 0.70
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yfhD membrane-bound
lytic murein
transglycosylase F
6.40 4.35 4.69 3.28 0.79
speC Ornithine
decarboxylase
SpeC
6.65 4.77 5.08 2.97 0.81
ykgJ predicted
ferredoxin
4.19 2.64 2.67 2.87 0.98
trxB thioredoxin-
disulfide
reductase
9.43 6.90 8.01 2.67 0.46
uraA uracil permease 6.67 4.27 5.34 2.53 0.48
12.2. Analyzing protein synthesis of biofilm-induced
genes
A few genes that were up regulated only in attached cells and not in planktonic cells were
selected. These selected genes are highlighted in the table x. The nucleotide sequences
lying upstream to these genes are likely to contain the regulatory elements that regulate
their expression. These nucleotide sequences, henceforth called promoters were cloned in
the vector pUA66 to generate reporter constructs. In the reporter construct, expression
of GFP acts as a proxy for the expression of the gene. Cells harboring these reporter
constructs were grown in the same way as they were grown for RNA isolation and the
level of GFP expressed in them was measured using flow cytometry. Unfortunately, out of
the tested constructs, only pVG56 (pahpC::gfp) showed detectable expression. However,
the level of expression from this promoter was found to be the same in all growth phases
(data not shown).
Planktonic cells in a biofilm represent those cells that are detached from the surface or
not yet attached to the surface. These cells remain in the close proximity of the biofilm
in the given settings of biofilm cultivation. Thus, genes up regulated in planktonic cells
can also be exploited to drive the synthesis of Dispersin B. In order to select such genes,
the transcriptome of planktonic cells was compared to that of the exponential phase cells
(table 12.2 ) and a few genes were shortlisted. Selected genes are highlighted in table
12.2. The genes rmf, aceB, astC, rpoS and fim were also included in the selected genes
that showed up regulation at p < 0.05 (data not shown).
77
12 12.2
Table 12.2. – List of the genes up regulated in planktonic cells w.r.t. exponential phase cells (>
4-fold)
Name DB Object
Name
Planktonic
cells
(total
RPKM)
Exponential
phase
cells
(total
RPKM)
Fold
change
P
value
T
value
glcD glycolate oxidase,
subunit GlcD
8.12 1.60 92.00 0.01 12.81
ssnA predicted
chlorohydro-
lase/aminohydrolase
6.84 1.28 47.13 0.01 17.80
cpxP Periplasmic stress
adaptor protein
CpxP
12.00 6.82 36.47 0.01 20.29
fadE acyl-coenzyme A
dehydrogenase
8.64 3.61 32.76 0.01 22.66
cysD sulfate adenylyl-
transferase, small
subunit
8.11 3.14 31.50 0.01 14.34
phoH ATP-binding
protein
9.34 4.45 29.59 0.00 39.65
cysA sulfate ABC
transporter,
ATP-binding
protein
8.01 3.31 25.95 0.01 20.62
cysU sulfate /
thiosulfate ABC
transporter -
membrane subunit
7.76 3.13 24.76 0.01 14.58
lsrB periplasmic AI-2
binding protein
LsrB
5.45 0.92 23.11 0.01 13.31
cysW sulfate ABC
transporter,
permease protein
7.69 3.20 22.46 0.01 14.41
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Table 12.2. – List of the genes up regulated in planktonic cells w.r.t. exponential phase cells (>
4-fold)
Name DB Object
Name
Planktonic
cells
(total
RPKM)
Exponential
phase
cells
(total
RPKM)
Fold
change
P
value
T
value
cysJ sulfite reductase
(NADPH)
flavoprotein
alpha-component
7.77 3.35 21.42 0.01 13.53
ego AI-2 ABC
transporter - ATP
binding subunit
5.95 1.57 20.79 0.01 18.15
ygfU urate:H+
symporter
4.26 -0.06 19.99 0.01 18.67
ygeX 2,3-
diaminopropionate
ammonia-lyase
7.03 2.76 19.30 0.01 20.48
glcG glcG protein 8.92 4.74 18.15 0.01 18.84
ygfM predicted
oxidoreductase
6.74 2.73 16.12 0.01 24.11
glcB malate synthase G 8.77 4.94 14.21 0.00 37.11
xdhD fused predicted
xan-
thine/hypoxanthine
oxidase
6.84 3.09 13.47 0.00 32.58
csrC a regulatory RNA 14.70 11.02 12.80 0.01 13.06
yghK glycolate /
lactate:H+
symporter
5.77 2.12 12.56 0.01 12.54
xdhA xanthine
dehydrogenase,
small subunit
6.33 2.95 10.38 0.00 38.96
yeeD conserved protein 8.99 5.67 10.00 0.01 12.40
hyuA hydantoin
utilization protein
A
5.17 1.93 9.42 0.01 16.37
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Table 12.2. – List of the genes up regulated in planktonic cells w.r.t. exponential phase cells (>
4-fold)
Name DB Object
Name
Planktonic
cells
(total
RPKM)
Exponential
phase
cells
(total
RPKM)
Fold
change
P
value
T
value
fadD long-chain-fatty-
acid–CoA
ligase
9.44 6.23 9.25 0.00 35.08
mokB 9.74 6.58 8.95 0.01 16.50
xdhB xanthine
dehydrogenase,
molybdopterin
binding subunit
5.27 2.20 8.38 0.01 16.46
ydeH diguanylate cyclase 7.04 4.25 6.91 0.01 16.89
csiE stationary phase
inducible protein
7.87 5.22 6.27 0.01 14.95
yfcX fatty oxidation
complex, alpha
subunit
8.34 5.70 6.26 0.01 20.24
yebE conserved inner
membrane protein
7.41 4.83 5.98 0.01 16.50
wzb protein-tyrosine
phosphatase
2.22 -0.34 5.92 0.01 13.77
pyrB aspartate car-
bamoyltransferase
6.28 3.73 5.83 0.01 17.68
argT lysine / arginine /
ornithine ABC
transporter -
periplasmic
binding protein
9.03 6.54 5.59 0.01 13.02
mltD membrane-bound
lytic murein
transglycosylase D
9.00 6.79 4.64 0.00 36.41
yobB conserved protein 6.82 4.66 4.46 0.01 19.97
80
12.3 12
Table 12.2. – List of the genes up regulated in planktonic cells w.r.t. exponential phase cells (>
4-fold)
Name DB Object
Name
Planktonic
cells
(total
RPKM)
Exponential
phase
cells
(total
RPKM)
Fold
change
P
value
T
value
prpR PrpR
DNA-binding
transcriptional
dual regulator
3.67 1.51 4.45 0.01 15.45
psiF 6.10 3.95 4.43 0.01 16.71
ydcJ 4.67 2.61 4.17 0.01 16.46
Promoters associated with these genes were cloned in the vector pUA66 and the level of
expression of GFP was measured in the same way as above. Some of the constructs in
this case also did not express any detectable GFP. However, the promoters of rmf, csrB
and fim showed high activity in the planktonic cells of the biofilm (figure 12.2). The
promoters of the genes aceB and fad showed more activity in the attached cells than in
the planktonic cells. However, their activity was too low to drive the synthesis of Dispersin
B.
Figure 12.2. – Activity of the selected promoters in the planktonic and the attached cells of the E.
coli W3110 biofilm
12.3. Expressing Dispersin B from the promoter of
the gene rmf
The reporter construct of the gene rmf was one of those, which showed high activity
in the planktonic cells of the biofilm. To test whether the promoter of rmf can drive
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the synthesis of Dispersin B, it was cloned upstream to ompA::dspB construct in the
plasmid pVG30. A strong ribosome binding site was introduced before the start codon of
ompA::dspB (Salis et al. , 2009b). The resultant construct was named as pVG46 (figure
12.3A). The cells harboring this construct were tested for the expression and secretion
of Dispersin B with the help of the secretion assay as described above. The cells could
express and secrete Dispersin B without adding any inducer. The secretion of Dispersin B
was almost 50% of that from original ompA::dspB construct induced at 100 μM of IPTG
(figure 12.3B).
To test the effect of this construct on biofilms, the pre-formed biofilm of E. coli TRMG1655
was treated with E. coli W3110 harboring the construct pVG46. The cells were able to
disrupt the ‘victim’ biofilm effectively (figure 12.3). However, the effect of the control
construct lacking the OmpA secretion signal was observed to be comparable to that of
pVG46. The same control construct did not show any secretion of the enzyme in the
secretion assay. This outcome was a bit counterintuitive and difficult to explain. It
requires more investigation in the mechanism of gene expression from the rmf promoter.
Figure 12.3. – Expressing Dispersin B from the promoter of the gene rmf A. Design of the con-
structs pVG45 and pVG46, B. Effect of the secreted enzyme on the pre-formed
TRMG biofilm and the secretion assay
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13. Using agr quorum-sensing
system of S. epidermidis
S. epidermidis possesses a quorum-sensing system termed agr, in which cells respond to
their own local density through a signaling molecule termed AIP (Olson et al. , 2014).
This system could be expressed in E. coli that would make E. coli responsive to AIP made
by S. epidermidis. Researchers have successfully exploited the quorum sensing system of
P. aeruginosa by expressing its components in E. coli (Choudhary & Schmidt-Dannert,
2010).
13.1. Expressing AgrC and AgrA of S. epidermidis
in E. coli
To test if the agr QS system can function in E. coli, the CDS of agrC and agrA from
S. epidermidis RP62A was cloned in the vector ptrc99a. The resultant construct was
names as pVG47.1. The intergenic region between RNAII and RNAIII of S. epidermidis
was cloned in the vector pUA66 to generate the construct pVG48.2. As described before,
cloning of any DNA fragment in the vector pUA66 enables us to measure promoter activity
of that fragment. E. coli cells harboring both the constructs pVG47.1 and pVG48.2 were
grown in the presence of 10 μM IPTG and 10 μg/ml AIP and the activity of RNAIII
promoter was measured by flow cytometry. The activity of RNAIII promoter showed
a small increment upon expression of AgrC and AgrA. However, there was no change
observed in RNAIII promoter activity due to the presence of the inducers (figure 13.1).
Perhaps, the proteins AgrC and AgrA were not functional in the intracellular environment
of E. coli.
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Figure 13.1. – Activity of the RNAIII promoter in the presence of the AIP when AgrC and AgrA of
S. epidermidis are expressed simultaneously
13.2. Generating chimeric constructs of AgrA and
its homologs in E. coli
The proteins AgrC and AgrA make a typical two-component system (TCS). AgrC is a
histidine kinase that senses the presence of AIP and phosphorylates AgrA. AgrA is a
response regulator, which upon phosphorylation activates the expression of RNAII and
RNAIII. Members of a TCS are modular and amenable to manipulations. Domains from
two different TCS proteins belonging to different species can be swapped to generate
chimeric proteins, which would exhibit a combination of functions of its constituents. One
such successful example is that of a chimera of Cph1 (from cyanobacteria Synechocystis
Sp.) and EnvZ (from E. coli). This chimera could sense light and respond to it by tran-
scriptional activation of a reporter through OmpR (response regulator of EnvZ) (Levskaya
et al. , 2005). There are some other successful examples of this kind (Weerasuriya et al. ,
1998; Michalodimitrakis et al. , 2005). However, this approach requires high similarity in
structures, and mechanisms of signal transduction of the constituent proteins (Salis et al.
, 2009a).
The histidine kinase AgrC belongs to a rare RHK family. The mechanism of signal trans-
duction of AgrC is unique and there is no structural or functional homolog found in E.
coli (Wang et al. , 2014). Thus, making a chimeric construct with any known histidine
kinase of E. coli was not possible. The second possibility was to construct a chimera of
AgrA and a similar response regulator of E. coli. AgrA is a typical response regulator with
an N-terminal phosphorylation and dimerization domain, and a C-terminal DNA-binding
domain. While most other response regulators share a similar architecture of DNA-binding
domain, AgrA possesses a different architecture known as LytTR domain (Sidote et al. ,
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2008). Upon surveying for other proteins with LytTR domains, two response regulators
YehT and YpdB from E. coli were found to contain the same domain. YehT is a response
regulator in YehU/YehT TCS that operates in stationary phase control network. YehT
activates the expression of YjiY by binding to its promoter (Kraxenberger et al. , 2012).
YpdB is a response regulator in YpdA/YpdB TCS that responds to the presence of pyru-
vate in the medium. The promoter of yhjX is the only target of YpdB (Fried et al. , 2013).
It was proposed that the chimeras of phosphorylation domain of AgrA, and DNA-binding
domain of YehT and YpdB each, could be phosphorylated by AgrC and activate the tran-
scription from their cognate promoters. Eventually, the cell would be able to respond to
AIP produced by S. epidermidis.
To test the proposed idea, chimeric DNA fragments of AgrA (aa 1-127) and YehT (aa 137-
239) and YpdB (aa 139-244) respectively were made by using overlap extension PCR. The
resultant fragments were cloned in the vector pTrc99a to make final constructs pVG47.2
and pVG47.3 respectively. Upstream DNA fragments of yhjX (cognate promoter of YpdB)
and yjiY (cognate promoter of YehT) were cloned in the vector pUA66 to generate the
constructs pVG49 and pVG50. The construct pVG47.2 was co-transformed with pVG49,
and pVG47.3 with pVG50. The activation of respective promoters was tested in the same
way as stated above. Unfortunately, there was no detectable expression observed from
the promoter of yhjX (data not shown). The activity of the yjiY promoter showed a
significant increase when the TCS was expressed in the same cell. However, there was no
difference in yjiY promoter activity upon addition of any of the inducers (figure 13.2).
Figure 13.2. – A. Design of the system involving the chimera of AgrA and YehT, B. Activity of the
yjiY promoter in the presence of the AIP when the chimeric protein AgrA-YehT is
expressed simultaneously
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14. Objective and strategy
Biofilms are aggregates of bacteria embedded in the self-produced matrix. The biofilm-
lifestyle is a unique feature of many bacteria, which enables them to survive through harsh
environmental conditions. For many years after the discovery of bacteria, it was considered
that they exist in a free-swimming or floating lifestyle. Most of the research concerning
bacteria was also conducted on the basis of this assumption. As the field of microbiology
grew further, it was observed that most bacteria exist in the form of biofilms.
Bacteria in the form of biofilms cause various infections in humans, animals, and plants.
Bio fouling in industrial settings is caused by biofilms and it leads to huge economic loss.
Researchers have attempted to develop different strategies to eradicate notorious biofilms.
However, the antibacterial agents that were effective against free-swimming or floating
bacteria are not equally effective in combating biofilms.
Biofilms are exceptionally resistant to the conventional methods of disinfection. This
gives rise to the need of developing novel and efficient methods of combating biofilms.
Among various methods tried and tested so far, biological methods have proved to be an
attractive choice. Bacteria, being simple and robust in their functioning, can be engineered
to perform a certain task. They can be engineered to disrupt a biofilm, which is otherwise
difficult to eradicate. This strategy can particularly be helpful in treating infectious diseases
where physical or chemical methods have not been successful. Thus, the objective of this
thesis was to design an engineered bacterial system that can efficiently disrupt a target
biofilm.
The strategy to accomplish this objective was planned in the following steps.
1. Choosing the ‘killer ’ and the ‘victim’
2. Choosing the ‘weapon’, i.e. an anti-biofilm agent that can be expressed in the ‘killer ’
and can disrupt the ‘victim’ biofilm
3. Choosing a suitable signaling pathway that can detect the presence of the ‘victim’
biofilm and synthesize the ‘weapon’ in response to it
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15. Choosing the ‘killer ’ and the
‘victim’
The first and foremost task was to select an organism, which can be engineered as ‘killer ’.
Escherichia coli is the most studied bacterium. E. coli has been used as a chassis to design
various biological systems involving genetic engineering. Thus, I decided to use E. coli for
this project.
The next step was to select the ‘victim’. E. coli biofilms are well-studied and a great deal
of information is known (Beloin et al. , 2008). Certain strains of E. coli are pathogenic,
and they are similar to the WT strains used in the lab. A system that can work against E.
coli biofilms can be modified and used against other similar pathogenic bacteria. Thus, I
decided to consider E. coli biofilm as one of the targets to design the proposed system.
Staphylococcus epidermidis is known to make biofilms on indwelling devices and cause
infections that are difficult to treat. The process of biofilm formation by S. epidermidis
and its composition has been studied well in detail (Otto, 2008). Developing a strategy
against a pathogenic organism has better prospects. Thus, I chose S. epidermidis biofilm
as another ‘victim’ to demonstrate the action of the proposed system.
15.1. Selecting Dispersin B as an anti-biofilm agent
The second step was to choose the most effective method of biofilm disruption that is
compatible with the engineered bacterial system. Most of the commonly used disinfectants
were artificially synthesized compounds that could not be synthesized biologically. Some
inhibitors of metabolism or signaling that were successfully used against bacterial biofilms
could be synthesized biologically. However, their synthesis involved many steps and it
was difficult to engineer bacteria for such a complicated synthesis process. Considering
the limitations of other biochemical agents, matrix-degrading enzymes were an attractive
choice. The only enzyme that was shown to be effective against E. coli biofilms as well
as S. epidermidis biofilms was Dispersin B. Dispersin B cleaves β, 1⇒6 glycosidic bond
that links NAG residues in poly-N-acetyl glucosamine (PGA) found in the matrix of E.
coli biofilms (termed as PIA or PNAG in S. epidermidis). This enzyme was a product of
a single gene that could be easily overexpressed in E. coli. Its synthesis involved a single
step, and it was not toxic to E. coli when overexpressed. Therefore, I decided to use this
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enzyme as a ‘weapon’ in the proposed system.
15.2. The action of Dispersin B on WT E. coli
biofilms
I tested the activity of purified Dispersin B on the pre-formed biofilms of various WT
strains of E. coli. It was observed that the effect of the enzyme was not significant on WT
E. coli biofilms. However, when the biofilms of these strains were grown in the presence
of Dispersin B, there was inhibition of biofilm formation (figure 9.2). In E. coli biofilms,
the polymer PGA is required for the transition of cells from temporary to permanent
attachment (Agladze et al. , 2005). The polymer is strongly associated with cells and
mostly localized at the cell poles (Itoh et al. , 2008). Along with PGA there are other
components in the biofilm matrix, such as Curli fibers, Type 1 fimbriae and cellulose. The
relative abundance of these components in the matrix depends on the kind of the strain
and the conditions of biofilm formation. All the components of the matrix are collectively
responsible for the structural integrity of the biofilm. Their relative contribution to the
integrity of the biofilm could be different in different strains and also varies according to
the conditions of growth. In the given experimental setting, it was observed that only
E. coli MG1655 contained PGA as an important component contributing to the integrity
of the biofilm. The biofilms formed by this strain were, however, less robust than other
WT strains. In case of other WT strains of E. coli, Dispersin B could not disrupt their
pre-formed biofilms. However, it inhibited their biofilm formation to varying extent. This
implies that these strains also contain PGA in their matrix and it is indeed involved in the
initial phase of biofilm formation. However, once the biofilm is formed, degrading PGA
does not significantly affect its structural integrity.
15.3. Selecting the biofilm of csrA mutant of E.
coli as a ‘victim’
CsrA (carbon storage regulator) is a global regulator in E. coli that regulates many un-
related functions in a post-transcriptional manner. CsrA plays an important role when
cells switch from the motile planktonic phase to sessile biofilm lifestyle. It drives the
cell more towards the motile planktonic phase and reduces its likelihood of acquiring the
biofilm-lifestyle. It binds to the 5’ untranslated region of pgaABCD mRNA, and inhibits
its translation. This results in the reduction of PGA synthesis. The csrA mutant used in
this thesis encodes the protein CsrA that is defective in its action of binding to the target
mRNA. The strain makes excess of PGA, and makes prolific biofilms. This mutation mim-
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ics that state of the cell, in which the cell is switching to the biofilm-lifestyle. Dispersin
B could efficiently disrupt the robust biofilms made by the csrA mutant (figure 9.3). This
observation proved that the biofilm of csrA mutant (E. coli TRMG1655) was an attractive
choice as a ‘victim’.
15.4. Secretion of Dispersin B
Various strategies have been explored to drive a recombinant protein out of the E. coli
cell. I decided to use the simplest method of fusing a secretion signal sequence of OmpA
to the N-terminus of Dispersin B. The secretion signal sequences from some other proteins
like FlgM and YebF were also tested. However, use of these signals was not successful in
driving Dispersin B out of the cell.
The presence of the secreted enzyme was detected by growing the cells in a medium
containing the substrate NP-GlcNAc. The presence of OmpA secretion signal sequence
could successfully drive the enzyme out of the cell. The expression and secretion of
Dispersin B was extremely slow. To observe at least 50 % reduction in the ‘victim’ biofilm,
the ‘killer ’ cells had to be incubated on top of the pre-formed ‘victim’ biofilm for at least
12 hours. This time span was too large in comparison to hardly one hour of incubation
required by the purified enzyme. The ’killer’ cell was incubated on the pre-formed biofilm
at 26 °C, without shaking. Under these conditions, E. coli cells grow slow and hence
the rate of the protein production is also slow. The protein OmpA is transported across
the inner membrane in Sec-dependent manner. The rate of transport of OmpA-Dispersin
B depends on the number of Sec proteins available in the cell. Consequently, not all
the enzyme that is synthesized inside the cell is transported out of the inner membrane.
After crossing the inner membrane, the enzyme has to cross another barrier of the outer
membrane. Limited numbers of the outer membrane secreton proteins further reduce the
rate of transport of the enzyme out of the cell. The enzyme activity was also detected in
the periplasmic fraction of the ’killer’ cells (data not shown) indicating that there was an
accumulation of Dispersin B in the periplasm. This explains why the ’killer’ cell required
long time of incubation to disrupt the ’victim’ biofilm.
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16. Using the N-Acetyl
glucosamine signaling pathway
in E. coli
The next step in accomplishing the objective of this project was to select the right sensory
pathway. I proposed three different strategies to engineer the ‘killer ’ so that it detects
the ‘victim’ biofilm and synthesizes Dispersin B as a response to the detection. The first
strategy involves using the N-acetyl glucosamine signaling pathway in E. coli.
N-acetyl glucosamine (NAG) is the constituent of PGA, which is the prominent component
of the matrix of the ‘victim’ biofilm. It was the most attractive choice for a signaling
molecule. E. coli possesses a set of genes that encode proteins involved in the uptake
and metabolism of NAG. These genes are expressed when the cell detects the presence of
NAG in the environment. Combining NAG metabolism with Dispersin B synthesis would
generate a ‘biofilm sense and destroy’ system. The ‘killer ’ would keep producing Dispersin
B as long as there is sufficient supply of NAG. Thus, I decided to use nagE promoter of
E. coli to drive the synthesis of Dispersin B.
16.1. NAG generated from the action of Dispersin
B was too low to activate the nagE promoter
In order to design the proposed system, it was essential to characterize how the nagE
promoter responds to extracellular NAG. The analysis of nagE promoter activity showed
that the nagE promoter required 50 μM of extracellular NAG to induce two-fold increase in
its activity. The induction of the nagE promoter was rather low in the presence of 1 to 10
μM of extracellular NAG. The concentration of NAG in the ’victim’ biofilm supernatant was
estimated by MBTH assay. It was less than 1 μM. The procedure of biofilm supernatant
preparation might not have isolated PGA in its entirety. Therefore, the results of the
MBTH assay were thought to be an underestimate. The same biofilm supernatant was
used to test the activity of the nagE promoter. Unfortunately, it could not activate the
nagE promoter above its basal expression level.
To circumvent the issue of dilution of NAG in the supernatant, the reporter cells harboring
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the construct pVG18 were incubated with the Dispersin B-treated ‘victim’ biofilm and the
activity of the nagE promoter was estimated by flow cytometry. Here, the reporter cells
were in the presence of the unprocessed biofilm and hence NAG generated from the biofilm
was in direct contact with the cells. In this experiment the reporter cells had low basal
expression of GFP. It was difficult to distinguish them from the cells of the ‘victim’ biofilm
while interpreting flow cytometry data. However, there was no obvious increase observed
in the activity of the nagE promoter.
16.2. Overexpressing the pgaABCD operon was
insufficient to elevate the levels of PGA
In E. coli, PGA is strongly associated with the cell surface and localized mainly to the
cell poles (Wang et al. , 2004). Once the cells are permanently attached, the expression
of PGA is perhaps not continued. As a result, the amount of PGA in the biofilm matrix
with respect to other components is not too high. In fact, researchers have found that
in the biofilm matrix of E. coli O157:H7, NAG is found to be hardly 1.9% of the total
carbohydrates (Bales et al. , 2013). Though there can be variation in the biofilm matrix
of different strains, this number cannot be expected to have significant variation. The
mutation in csrA increased the synthesis of PGA. This increase was enough to make a
substantial change in the morphology of the biofilm. The mutation also made PGA as
the most prominent component of the biofilm matrix. However, it could not result in
generating the amount of NAG that was necessary to activate the nagE promoter.
To elevate the levels of PGA synthesized by the ‘victim’ biofilm, entire pgaABCD operon
was overexpressed in the csrA mutant of E. coli. However, the highest level of overexpres-
sion of pgaABCD operon resulted in less than 2.5 fold increase in biofilm formation. The
biofilm overexpressing pgaABCD operon was treated with Dispersin B and the activation
of the nagE promoter was assessed by incubating the reporter cells on top of the treated
biofilm. Unfortunately there was no significant increase observed in nagE promoter activ-
ity. Although overexpressing pgaABCD operon resulted in increasing PGA production, the
hydrolysis of PGA into NAG was not sufficient to induce the nagE promoter. The level
of PGA production depends not just on the level of expression of enzymes involved in its
synthesis, but also on other factors. For example, cyclic-di-GMP generated from the ac-
tion of DgcZ is necessary for the assembly of the export machinery of PGA (Steiner et al.
, 2013). Perhaps the action of DgcZ was limiting the overproduction of PGA. Therefore,
despite overexpressing the entire pgaABCD operon there was less than 2.5 fold increase in
biofilm formation. Due to limited amount of PGA, its hydrolysis could not generate high
concentration of NAG, and the expected increase in the activity of the nagE promoter
was not observed.
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Although the amount of PGA synthesized by cells was low, the action of Dispersin B was
able to disrupt the ‘victim’ biofilm completely. This implies that PGA, although present
in little amount was important for the structural integrity of the ‘victim’ biofilm. Ideally,
the action of purified Dispersin B should have generated many molecules of NAG after
complete hydrolysis of the polymer. However, the difference in the concentration of NAG
between Dispersin B treated and untreated samples, as observed by MBTH assay, was too
low. It indicates that the action of Dispersin B did not hydrolyze the entire polymer. The
reason behind this could be the exolytic action of the enzyme (Kerrigan et al. , 2015).
Hydrolysis of a few residues of the polymer was sufficient to disrupt the structural integrity
of the biofilm. However, it did not generate enough molecules of NAG. Researchers came
across a similar observation in case of S. epidermidis biofilms (Goekcen et al. , 2013). They
observed that Dispersin B at a concentration as low as 1 μg/ml could efficiently disrupt
S. epidermidis biofilms. However, to see a detectable amount of NAG the concentration
of Dispersin B needed was as high as 1000 μg/ml.
16.3. Sensitivity of the nagE promoter could not be
improved
Attempts were made to improve the sensitivity of the nagE promoter by tweaking the
levels of the components of the nagE/BACD operon. The idea behind this was to alter
the basal levels of NAG-6-P inside the cell so that the cell becomes more sensitive to
extracellular NAG. Overexpression of NagC (the repressor) reduced the activity of the
nagE promoter at all the concentrations of extracellular NAG. Overexpressing the catabolic
enzymes NagB and NagA resulted in the same outcome. When NagE (the transporter of
NAG) was overexpressed, it resulted in the increase in the activity of the nagE promoter
for all concentrations of extracellular NAG. In any of these attempts, the fold-change in
the activity of the nagE promoter in the range of 1 to 10 μM of extracellular NAG was
unaffected.
The enzymes encoded by the genes in the nagE/BACD operon play an important role
in peptidoglycan recycling. When cells are dividing, they are constantly breaking down
and synthesizing peptidoglycan, which is a component of the cell wall. Since NAG is a
major constituent of peptidoglycan, there is always some level of NAG-6-P present inside
the cell. Although enzymes encoded by the genes in the nagE/BACD operon have a
major contribution in NAG metabolism, there are alternative pathways present in the cell,
which compensate for the loss or overexpression of genes in the nagE/BACD operon.
For example, NagK phosphorylates NAG generated from the hydrolysis of peptidoglycan
oligomers and makes NAG-6-P. This action maintains the basal level of NAG-6-phosphate
inside the cell when NagB and NagA are overexpressed. In short, metabolism of NAG
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quickly adjusts itself in such a way that any perturbations in its components would result in
minimal change in the levels of NAG metabolites inside the cell. These perturbations could
have a detectable effect on the activity of the nagE promoter at higher concentrations
of extracellular NAG. However, the proposed system required that the nagE promoter is
able to detect extremely low concentration of NAG generated from the ‘victim’ biofilm.
Thus, tweaking the levels of the enzymes involved in NAG metabolism was ineffective for
the proposed system.
Apart from the low amount of PGA in the ‘victim’ biofilm and low sensitivity of the
nagE promoter, there was another hurdle in making the proposed system work. It was
the mismatch between the time required for the expression and secretion of Dispersin
B and the time required for the activation of the nagE promoter. The activity of the
nagE promoter at 100 μM of extracellular NAG, started declining within ~ 90 minutes
after the addition of NAG (figure 10.1). This was the case when the cells were growing
exponentially in the presence of NAG at 37 °C and shaking at 200 rpm. The decline in
the activity was mainly due to the presence of the catabolic enzymes NagB and NagA. As
described in section 4.1, the expression of the catabolic enzymes NagB and NagA is also
up regulated when the cell takes up NAG from the environment. The increasing catabolic
activity of these enzymes results in the complete utilization of NAG and decline in the
activity of the nagE promoter. Since the enzymes of NAG metabolism are involved in
peptidoglycan recycling, their turnover is higher is fast-growing cells. Hence, the transient
activation of the nagE promoter was observed. In the conditions of biofilm disruption (26
°C and without shaking) the ’killer’ cells grow slow. Hence, the change in the activity
of the nagE promoter was found to be much lesser and slower than that observed in the
former condition (data not shown). As evident from figure 9.5, the ‘killer ’ cells required
at least 12 hours of incubation to secrete Dispersin B that brought about 50% disruption
of the ‘victim’ biofilm. Thus, even if the nagE promoter had been sensitive enough to
detect the low amount of NAG generated from the ‘victim’ biofilm, driving the expression
of Dispersin B from the induction of NAG would have been difficult to execute.
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17. Using chemotaxis to enhance
the efficiency of the system
Combining chemotaxis with the proposed system was indeed an attractive strategy. By
using chemotaxis, the ‘killer ’ specifically migrates towards the ‘victim’ biofilm and secretes
Dispersin B only in the vicinity of the ‘victim’ biofilm. The fact that E. coli is chemotactic
towards NAG was known (Adler et al. , 1973). However, its exact mechanism was not
explored. In this project, it was found that the chemotaxis towards NAG is PTS medi-
ated and not receptor mediated. Also, it was observed that the range of concentration
within which E. coli shows chemotaxis towards NAG is between 1 to 10 μM. Since the
concentration of NAG at some distance away from the biofilm would be much lower than
this range, it was necessary that the ‘killer ’ shows chemotaxis towards NAG at a relatively
lower concentration.
For the PTS-mediated chemotaxis pathway, the protein involved in binding to the extra-
cellular sugar is the transporter of that sugar. It is the uptake of the sugar through the
transporter initiates the cascade of reactions that eventually lead to chemotaxis. In case of
chemotaxis towards NAG, it is the transporter NagE, which performs this important role.
In order to improve the chemotaxis towards NAG, the transporter NagE overexpressed
and the chemotactic response of the cells was studied by stimulus-dependent flow-FRET.
The modern biophysical technique of flow-FRET allowed the quantitative analysis of the
chemotactic response. NagE being a membrane protein, its overexpression in the WT cells
resulted in slower growth and lack of fluorescent signal in the flow-FRET setup. Hence,
the transporter was overexpressed in the deletion mutant of the transporter itself. Un-
fortunately, there was no change in the range of the concentration within which the cells
show chemotaxis towards NAG.
The PTS-mediated pathway of chemotaxis is not as modular as the receptor-mediated
pathway. In fact, the exact mechanism of interaction of PTS proteins with the chemotactic
proteins is not completely understood. The only aspect that is understood so far is that
PtsI directly interacts with CheA and influences its kinase activity (Neumann et al. , 2012).
The possible reason behind the above observation is that that the amount of PtsI present
in the cell is limited. More transporters bring more NAG inside the cell, however there are
no sufficient levels of PtsI present in the cell to transduce the signal. This speculation
required further experiments, which was beyond the scope of this thesis.
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18. Using biofilm-specific gene
expression
The second strategy is about exploiting the biofilm-specific gene expression in E. coli to
drive the synthesis of the ‘weapon’. The biofilm mode of lifestyle is fundamentally different
from the planktonic lifestyle. The phenotypic characteristics of biofilms are thought to be
regulated by a specific pattern of gene expression. In the perspective of this project, such
biofilm-specific up regulation of genes can be regarded as a signaling pathway. Although
the presence of any signaling molecule is debatable, the output of this imaginary signaling
pathway is certainly attractive for this project. If such a gene(s) is found, the promoter
associated with it can be used to drive the expression of Dispersin B. The ‘killer ’ will
approach the ‘victim’ biofilm, get incorporated into the biofilm and start expressing the
enzyme once it acquires the lifestyle of a biofilm. This will eventually disrupt the biofilm
from within.
Researchers have explored into the biofilm-specific gene expression by DNA microarray-
based techniques. However, there is no unanimous outcome of different experiments. The
observations from the previous studies imply that the pattern of gene expression depends
on the conditions in which biofilms were grown. Thus, I thought of exploring the pattern of
gene expression in E. coli biofilms grown under conditions relevant to the objective of this
project. I used the most advanced and sensitive method of RNA-seq. The transcriptome
of the planktonic cells and the attached cells of the WT E. coli biofilms was compared
with that of the exponential phase cells of the same. It was found that most of the genes
up regulated in attached cells were also up regulated in planktonic cells. However, these
findings were in agreement with the previous work (Beloin et al. , 2004). Most of the
genes that were found to be up regulated in biofilms encode proteins involved in metabolic
processes such as glycolate metabolism, fatty acid oxidation, oxidoreductase activity, and
others. There were also some genes, which are involved in responding to extracytoplasmic
stress (cpxP), regulation of capsule synthesis (rcsB), regulation of curli assembly (csgD)
and some other regulatory functions.
The data were further sorted to find those genes, which are up regulated only in attached
cells and not in planktonic cells of the biofilm with respect to the exponential phase cells. A
set of such genes was shortlisted and their corresponding promoters were cloned upstream
to the CDS of gfp to make the reporter constructs. These reporter constructs were then
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tested for protein synthesis under the same conditions, in which cells were grown for RNA
isolation. Most of these reporter constructs did not show any detectable expression. This
could be due to the lack of regulatory elements in the DNA fragments used to make these
constructs.
Planktonic cells of the biofilm are those cells, which are either dispersed from the biofilm
or not attached at all. In the given experimental setting, they are floating in the close
vicinity of the biofilm. It was possible to drive the expression of Dispersin B from one
of the planktonic-phase promoters. The enzyme could diffuse to the biofilm and disrupt
the biofilm. In order to find such a promoter, the genes up regulated in planktonic cells
were further sorted and a few of the genes were selected. The activity of the promoters
associated with these genes was measured in different phases of the cells.
The promoter of the gene rmf showed high expression in planktonic cells of the biofilm.
This gene encodes a ‘ribosome modulating factor’ that is overexpressed when the cells
enter stationary phase. Rmf binds to 70S ribosomal subunit inducing its dimerization that
in turn inhibits the binding of the ribosome to mRNA. Thus, overexpression of Rmf results
in slowing down of translational activity of the cell. As cells acquire the biofilm-lifestyle
they show slowed growth rate and metabolic activity (Wada et al. , 1995). The metabolic
state of a cell in a biofilm is quite similar to that in a stationary phase. Thus, it was
intuitive to find the overexpression of Rmf in the planktonic cells of a biofilm. Although
the overexpression of Rmf was not biofilm-specific, I decided to use the promoter of
the gene rmf to drive the expression of Dispersin B. The ‘killer ’ cells could successfully
synthesize and secrete Dispersin B when expressed from the rmf promoter. However,
the cells carrying the constructs with and without the secretion signal did not show any
significant difference in their activity on the biofilm. This outcome was surprising and
difficult to explain. As shown in figure 12.3, the constructs with and without the secretion
signal show the expected difference in the secretion of the enzyme. The secretion assay
was performed by growing the cells in the M9 minimal medium. To observe the change
in the color of the substrate, a transparent medium is necessary. The LB medium, being
yellow in color is unsuitable for the secretion assay. When the cells were used to disrupt
the ’victim’ biofilm, they were grown in the LB medium to achieve higher growth rate and
higher enzyme production. It is possible that the growth of the cells in the LB medium had
an effect on the way genes are expressed from the rmf promoter. In the late stationary
phase, when the rmf promoter is activated, the cells are perhaps leaky (Casadei et al.
, 2002). They tend to release some proteins regardless of the presence of the secretion
signal. This speculation, however, requires further investigation.
97
19. Using the agr quorum-sensing
system of S. epidermidis
S. epidermidis harbors a quorum-sensing system called agr (accessory gene regulator)
system by which, the cells respond to their own local density via a signaling molecule
called AIP (auto-inducing peptide). Cells within the biofilm of S. epidermidis regulate the
expression of many genes through this system. Thus, the signaling molecule AIP was an
attractive molecule to be exploited to detect the presence of the biofilm. Components of
the quorum-sensing system in Pseudomonas aeruginosa have been successfully expressed
in E. coli (Choudhary & Schmidt-Dannert, 2010). On the similar lines it was proposed that
the agr system of S. epidermidis could be expressed in E. coli to detect the presence of the
S. epidermidis biofilm. To test this hypothesis, the promoter that responds to the quorum
sensing system was cloned upstream to the CDS of GFP to make a reporter construct and
the components involved in sensing were co-expressed along with it. Unfortunately, the
reporter construct did not respond to the AIP molecules in the medium. The components
of the agr system were not functional in E. coli.
Generating chimeric proteins is an excellent strategy to combine the properties of two
different proteins. The protein AgrA of S. epidermidis shared sequence and domain-
organization similarity with two proteins of E. coli, YehT and YpdB. Thus, it was pro-
posed to generate chimeric proteins containing phosphorylation domain of AgrA and
DNA-binding domain of YehT and YpdB respectively. The promoters associated with
YehT and YpdB were cloned to make reporter constructs. The reporter construct of yjiY
(cognate promoter of yehT ) showed an increase in its activity when the chimeric protein
AgrA-YehT and AgrC were expressed. However, there was no response observed to the
AIP. Generating functional chimeric proteins has been successful in some lucky instances
where the two parent proteins had a striking similarity in the structure and the mechanism
of signal transduction. In this case, both YehT and YpdB contain a LytTR domain that
is also found in AgrA (Sidote et al. , 2008). The function of this domain is to bind a
specific sequence of DNA and activate the gene expression. However, the ability of this
domain to bind DNA depends on the phosphorylation state of the other domain (in this
case, CheY-like domain). Perhaps, it is the phosphorylation-induced change in the confor-
mation of the protein that dictates the DNA-binding ability of the LytTR domain. This
conformational change can be different for different proteins. Generating chimeras of two
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proteins with different patterns of the conformational change may not result in functional
chimeric protein. In this case, the exact pattern of the conformational change is unknown.
Thus, it is difficult to generate a functional chimera of these proteins.
Apart from the functionality of the chimeric proteins, the functionality of the receptor
AgrC also needs to be considered. AgrC is a membrane bound histidine kinase, which
senses the presence of the AIP and phosphorylates AgrA. According to the structure and
the mechanism of signal transduction, AgrC belongs to a rare family of proteins. It was
possible that its functioning required the microenvironment of the cell membrane of a
typical Gram-positive bacterium. Since the receptor itself was perhaps not functional in
E. coli, it was unlikely that E. coli could respond to the AIP.
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20. Conclusion and future
prospects
The objective of this thesis was to design a biologically engineered system to combat
bacterial biofilms. I have successfully shown that a matrix-degrading enzyme- Dispersin
B can be an efficient ’weapon’ to destroy the target biofilm. The enzyme can be easily
overexpressed and secreted by the ‘killer ’ cell. The next step in accomplishing the goal of
this project was to combine the expression of Dispersin B with a suitable signal transduction
pathway. I attempted to exploit the NAG metabolic pathway, the NAG chemotaxis pathway
and biofilm-specific gene expression to achieve this goal. Alternatively, I designed a similar
system to disrupt the biofilm of S. epidermidis. In this system, I attempted to use the agr
quorum sensing system to engineer the ‘killer ’ that can disrupt S. epidermidis biofilms.
In the course of accomplishing the objective of this project, I have explored the metabolic
pathway of NAG and the chemotactic pathway of NAG in E. coli. Although certain facts
were already known about these pathways, I have unraveled some interesting features of
these pathways. The chemotactic pathway of E. coli is sensitive to extracellular NAG
within the range of 1 to 10 μM. Whereas for the catabolic pathway of NAG, the same
range of concentration is insignificant. The nagE promoter shows a significant increase in
its activity only beyond 10 μM of extracellular NAG.
While demonstrating the effect of Dispersin B on E. coli biofilms, I have indirectly inves-
tigated the relative importance of PGA in biofilm formation. It was observed that PGA
becomes critical to the structural integrity of the biofilm only when it is synthesized in
excess. In the WT strain of E. coli, PGA is important only in initial stages of biofilm
formation. Once the mature biofilm is formed other components of the matrix become
more important than PGA.
Exploring the biofilm-specific pattern of gene expression has been the most interesting
task performed in this project. The general trend observed in the genes overexpressed in
biofilms was more or less in agreement with previous studies. Considering great differences
in opinions shared by scientists regarding gene expression in biofilms, this observation is
remarkable. The genes that were found to be up regulated only in attached cells but
not in planktonic cells encode for enzymes involved in combating oxidative stress. It is
counter-intuitive to see oxidative stress in the deeper layers of a biofilm. Perhaps it is an
indirect effect that takes place through an unknown protein. It is certainly worth exploring
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this question further.
In the context of the bacterial species used in this thesis, the proposed system was only
partially successful. However, the idea underlying this project is extremely versatile and
still holds a possibility of being successful in some other species of bacteria. The idea
requires finding an abundant and important component of a biofilm matrix, an enzyme
that degrades this component and a signaling pathway that responds to the product of
the action of the enzyme. For example, the biofilm matrix of P. aeruginosa contains
alginate that is essential for its structural integrity. The enzyme alginate lyase is known
to degrade alginate and generate uronic acids as products of its action. It is possible
to engineer E. coli to express alginate lyase from the promoter associated with uronic
acid metabolism. The ‘killer ’ cell would continue producing the enzyme as long as there
are enough uronic acids being generated from the biofilm. The same module can be
extended to any other bacteria for which the above details are known. The concept of
exploiting biofilm-specific gene expression does not even require the presence of a specific
metabolic pathway. Identification of a gene that is multi-fold up regulated upon acquiring
a biofilm-lifestyle is sufficient for extending the model to other species of bacteria.
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i
List of strains
Following is the list of strains used in this study (Table 20.1).
Table 20.1. – List of strains
Name of the
strain
Genotype Antibiotic
Resis-
tance
Source and
reference
E. coli MG1655 F- λ- ilvG- rib-50 rph-1 none Received from
G. Krammer
(ZMBH,
University of
Heidelberg)
(Hayashi et al. ,
2006)
E. coli K12
W3110
F- λ- INV(rrnD, rrnE) rph-1 none Received from
G. Kramer
(ZMBH,
University of
Heidelberg)
(Hayashi et al. ,
2006)
E. coli K12
W3110 ΔfliC
F- λ- INV(rrnD, rrnE) rph-1
ΔfliC
none Received from
Verena
Suchanek
E. coli K12
LJ110
W3110, F-, Fnr+ none (Zeppenfeld
et al. , 2000)
E. coli K12
LJ110 ΔnagE
W3110, F-, Fnr+, ΔnagE Kan This work
E. coli K12
LJ110
ΔptsIΔcpdA
W3110, F−, Fnr+, ΔptsIΔcpdA Kan Dr. Karin
Grosse
E. coli UU1250 RP437 Δaer -1 ygjG::Gm
Δtsr -7028 Δ(tar-tap)5201
zbd::Tn5 Δtrg -100 thr+met+
none (Ames et al. ,
2002)
E. coli K12
W3110 RH
F- λ- INV(rrnD, rrnE) rph-1 none Received from
Dr. Regine
Henge
(Humboldt
University,
Berlin)
(Hayashi et al. ,
2006)
E. coli K12
W3110 AR
F- λ-IN(rrnD-rrnE) rph-1 none Received from
Dr. Regine
Henge
(Humboldt
University,
Berlin)
(Serra et al. ,
2013)
E. coli M15
(contains
pREP4)
F-, Φ80ΔlacM15, thi, lac-, mtl-,
recA+, KmR
Kan Quiagen
E. coli
TRMG1655
E. coli K12 MG1655 csrA::kan Kan Received from
Dr. Tony
Romeo
(University of
Florida)
(Romeo et al. ,
1993)
E. coli DH5α F- endA1 glnV44 thi-1 recA1
relA1 gyrA96 deoR nupG
Φ80dlacZΔM15
Δ(lacZYA-argF)U169,
hsdR17(rK- mK+), λ–
none Invitrogen
S. epidermidis
RP62A
none ATCC
List of plasmids
Following is the list of plasmid constructs made in this study (Table 20.2)
Table 20.2. – List of plasmids
Name of the
Plasmid
Fragment cloned Cloning
vector
Antibiotic
re-
sis-
tance
pVG17 nagE pBAD33 cam
pVG18 nagE promoter::GFP pUA66 kan
pVG21 ompA::dspB pQE60 amp
pVG22 dspB pQE60 amp
pVG23 nagC ptrc99a amp
pVG24 nagB nagA pBAD33 cam
pVG29 dspB ptrc99a amp
pVG30 ompA::dspB ptrc99a amp
pVG31 rmf promoter pUA66 kan
pVG32 prpB promoter pUA66 kan
pVG33 wza promoter pUA66 kan
pVG35 csrB promoter pUA66 kan
pVG36 aceB promoter pUA66 kan
pVG37 astC promoter pUA66 kan
pVG38 cysJ promoter pUA66 kan
pVG39 cpxP promoter pUA66 kan
pVG40 rpoS promoter pUA66 kan
pVG41 pgaABCD pBAD33 cam
pVG42 pgaABCD pBAD24 amp
pVG45 prmf::RBS2::dspB ptrc99a amp
pVG46 prmf::RBS2::ompA::dspB ptrc99a amp
pVG47.1 agrC agrA of S. epidermidis ptrc99a amp
pVG47.2 agrC agrA::ypdB ptrc99a amp
pVG47.3 agrC agrA::yehT ptrc99a amp
pVG48.2 RNAIII promoter pUA66 kan
pVG49 yhjX promoter pUA66 kan
pVG50 yjiY promoter pUA66 kan
pVG51 fim promoter pUA66 kan
pVG52 fad promoter pUA66 kan
pVG53 trxC promoter pUA66 kan
pVG54 grxA promoter pUA66 kan
pVG55 oxyS promoter pUA66 kan
pVG56 ahpC promoter pUA66 kan
Following is the list of cloning vectors and other plasmids used in this study (Table 20.3)
Table 20.3. – List of cloning vectors
Name of the
Plas-
mid/Vector
Specification Antibiotic
resistance
Source and
reference
pBAD24 ori pBR322, PBAD promoter Amp Guzman et al. ,
1995
pBAD33 ori pBR322, PBAD promoter Cam Guzman et al. ,
1995
pQE60 ori ColE1, PTAC promoter Amp Quiagen
pTrc99a ori pBR322, PTAC promoter Amp Amann et al. ,
1988
pUA66 ori Sc101, gfpmut3 Kan Zaslaver et al. ,
2006
pJK618 dspB Amp Kaplan et al. ,
2003
pVS88 cheY-yfp cheZ-cfp Amp Sourjik et al. ,
2007
List of primers
Following is the list of primers used in this study (Table 20.4)
Table 20.4. – List of primers
Name
of the
Primer
Sequence For the
amplification of
Restriction
site
VG17f ATCGAGCTCTCGTAGGGGGAATA
AGATGA
nagE CDS of E. coli
with RBS
SacI
VG17r GTCTCTAGATTACTTTTTGATTTCAT
ACAGCGG
nagE CDS of E. coli
with RBS
XbaI
VG18f TGACTCGAGTGCGCAGACAGGCG
TCAATC
nagE promoter of E.
coli
Xho1
VG18r CGTGGATCCCTTATTCCCCCTACG
AGAACCCTATTTG
nagE promoter of E.
coli
BamH1
VG23f AAATTACCATGGGAATGAAAAAAAC
CGCGATTGCGATTGCGGTGGCGCT
GGCGGGCTTTGCGACCGTGGCGC
AGGCGAAT
dspB with ompA
secretion tag
Nco1
VG23rB GTGATGAGATCTGGATCCCTCAT
CCCCATTCGTCTTAT
dspB BamH1
VG24f AAATTACCATGGGAATTGTTGCG
TAAAAGGCA
dspB without ompA
secretion tag
Nco1
VG24r GTGATGAGATCTGGATCCGCCTCC
GCCTCCGCCCTCATCCCCATTCGT
CTTAT
dspB with glycine
linker
BamH1
VG26f AATTCGAGCTCTGAGGTGAATAAT
GAG
ACTGA
nagBA genes of E. coli Sac1
VG26r TCGACTCTAGAGCCTGGTGTCATAC
TTT
CTC
nagBA genes of E. coli Xba1
VG37f ACTGCTCGAGTTGTAAATATAACCG
TCT
CCG
rmf promoter of E. coli Xho1
VG37r ACTGGGATCCGCCTCGTTTCCCTC
ATAC
rmf promoter of E. coli BamH1
VG38f ACTGCTCGAGTTGTTGCAATGAAA
CGCGG
prpB promoter of E.
coli
Xho1
VG38r ACTGGGATCCGCCCATCCTTTGTT
ATCAACT
prpB promoter of E.
coli
BamH1
VG39f ACTGCTCGAGCAAAACCTATTCGT
TGTATGAC
wza promoter of E.
coli
Xho1
VG39r ACTGGGATCCTTGTTTATTTATCAC
TTTGGCAG
wza promoter of E.
coli
BamH1
VG41f ACTGCTCGAGCCATCTGGTTGTGA
GAGAT
csrB promoter of E.
coli
Xho1
VG41r ACTGGGATCCCCCTGTCGACGAA
GATAGAA
csrB promoter of E.
coli
BamH1
VG42f AGTCCTCGAGGTTATACCGCCAG
TAATGCT
fimA promoter of E.
coli
Xho1
VG42r ACTGGGATCCTGTAGAACTGAGG
GACAGAG
fimA promoter of E.
coli
BamH1
VG43f ATCGCTCGAGAACGCTGGATTAA
TCTTCTGTG
aceB promoter of E.
coli
Xho1
VG43r ATCGGGATCCTTCAGTCATCGTG
CAGCTC
aceB promoter of E.
coli
BamH1
VG44f ACTGCTCGAGTGTAAAGCATGTC
AGTCTCC
fadB promoter of E.
coli
Xho1
VG44r ACTGGGATCCAGGCCAGTGATTC
CATTTTT
fadB promoter of E.
coli
BamH1
VG45f TGACCTCGAGCAGGCCGTTGATA
TTAAAAGA
astC promoter of E.
coli
Xho1
VG45r TACGGGATCCAAGTTTTCACGCG
TAATTGG
astC promoter of E.
coli
BamH1
VG46f AGTCCTCGAGGAAATCTTTAAATA
ACGTGGTGG
cysJ promoter of E.
coli
Xho1
VG46r TGACGGATCCGTCATGCGTCGTT
ATGTTC
cysJ promoter of E.
coli
BamH1
VG48f TACGCTCGAGTCGGTCATCATCA
ACTAACA
cpxP promoter of E.
coli
Xho1
VG48r ACTGGGATCCCTATGCGCATCAT
TTGCTC
cpxP promoter of E.
coli
BamH1
VG50f TCGACTCGAGGATAAATCGGCG
GAACCAG
rpoS promoter of E.
coli
Xho1
VG50r ACTGGGATCCCTGCGATAACAGT
TCCTCTT
rpoS promoter of E.
coli
BamH1
VG51fk GCTCGGTACCCAATACATGGAGT
AATACAGGA
pgaABCD operon of E.
coli
Kpn1
VG51r GTCGATCTAGAGGTGTTTATGCC
CGGACT
pgaABCD operon of E.
coli
Xba1
VG52f ATCGGATATCTTGTAAATATAACC
GTCTCCG
rmf promoter of E. coli EcoRV
VG52r ACAGACCATGGGCCTCGTTTCCC
TCATAC
rmf promoter of E. coli Nco1
VG53f TAGCGAATTCATGGATGATATTAA
TCTATTTCCG
agrCagrA CDS of S.
epidermidis
EcoR1
VG53r TCAGGGATCCTGGGTGTTTCATTA
TATTTTT
agrCagrA CDS of S.
epidermidis
BamH1
VG53rB CACCAGATTAATCGTATCTACAT
TACTTTCTTTTG
agrCagrA CDS of S.
epidermidis, contains
overlapping sequence
with VG57f
VG53rT CGTACAAGGGATCGTATCTACAT
TACTTTCTTTTG
agrCagrA CDS of S.
epidermidis, contains
overlapping sequence
with VG58f
VG54rb TGCAGGATCCACTACTCTCCTCA
AGTGTCA
RNAIII promoter of S.
epidermidis
BamH1
VG54rx AGTCCTCGAGACTACTCTCCTCA
AGTGTCA
RNAIII promoter of S.
epidermidis
Xho1
VG55f AGTCCTCGAGGGTTAGCGCCAG
ATTTTAAC
yhjX promoter of E.
coli
Xho1
VG55r TGCAGGATCCAAGGTGTCATGG
CAGTATTC
yhjX promoter of E.
coli
BamH1
VG56f ATCGCTCGAGTATCCATAGTAAA
ACCTGGCAT
yjiY promoter of E.
coli
Xho1
VG56r TCGAGGATCCTGATACGTTTTAA
CATGGTTTCT
yjiY promoter of E.
coli
BamH1
VG57f AATGTAGATACGATTAATCTGGT
GAAAGATGAGC
lytTR domain of ypdB
gene of E. coli
VG57r TCAGGGATCCTTAAAGATGCATT
AACTGGCG
lytTR domain of ypdB
gene of E. coli
BamH1
VG58f AATGTAGATACGATCCCTTGTAC
GGGGCATAG
lytTR domain of yehT
gene of E. coli
VG58r TCAGGGATCCTTACAGGCCAAT
CGCCTCTTTT
lytTR domain of yehT
gene of E. coli
BamH1
VG70f GATCCTCGAGTTCATGCTTTTC
TCCACCAG
trxC promoter of E.
coli
Xho1
VG70r GTACGGATCCCTAACCTCGGGA
TGAGTAAG
trxC promoter of E.
coli
BamH1
VG71f GATCCTCGAGATCGCGCGCATA
CGCTTCC
grxA promoter of E.
coli
Xho1
VG71r GATCGGATCCTATTTCTCTCCTC
ATAGATTTATGCCTGT
grxA promoter of E.
coli
BamH1
VG72f GATCCTCGAGCATTATCCATCCT
CCATCGC
oxyS promoter of E.
coli
Xho1
VG72r GATCGGATCCTCCGTTTCTGTG
AGCAATTA
oxyS promoter of E.
coli
BamH1
VG73f GATCCTCGAGAAGCAGAGCCAG
TAAAAGTAT
ahpC promoter of E.
coli
Xho1
VG73r GATCGGATCCTCTATACTTCCTC
CGTGTTT
ahpC promoter of E.
coli
BamH1
List of abbreviations
Table 20.5. – List of abbreviations
Abbreviation Full form
AIP Auto-inducing peptide
amp Ampicillin
CDS Coding sequence
CFP Cyan fluorescent protein
DNA Deoxyribonucleic acid
EDTA Ethylenediaminetetraacetic acid
FRET Fluorescence Resonance Energy Transfer
GFP Green fluorescent protein
IPTG Isopropyl ß-D-1 thiogalactopyranoside
kan Kanamycin
LB Luria-Bertani
MBTH 3-methyl-2-benzothiazolone hydrazone
hydrochloride
MCP Methyl-accepting chemotaxis protein
mRNA Messenger RNA
NAG N-acetyl glucosamine
NP-GlcNAc 4-nitrophenyl N-acetyl-ß-D-glucosaminide
OD Optical density
PEG Poly ethylene glycol
PGA Poly N-acetyl glucosamine
PTS Phosphotransferase system
RBS Ribosome Binding Site
RNA Ribonucleic acid
rpm Rotations per minute
SDS-PAGE Sodium dodecyl sulfate - Polyacrylamide Gel
Electrophoresis
TAE Tris acetate EDTA
TB Tryptone broth
TCS Two-component system
TE Tris-EDTA
TSS Transformation storage solution
YFP Yellow fluorescent protein
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